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MOFs are a versatile class of porous materials made from metal ions and organic ligands. 
The structural and functional diversity of these materials allows them to be used in wide 
variety of applications. However, the mechanisms behind crystal growth are far from fully 
understood. As a result, control of the MOF particle size has remained largely inconsistent. 
Several methods have been used to control MOF particle size including microwave assisted 
synthesis and adjusting the metal: ligand ratio. Recently, researchers have begun to explore 
the use of microemulsions as an environment to synthesize precise size-controlled nanoscale 
MOFs. However, this field has been largely unexplored. Herein it is proposed that a non-
ionic water/hexanol/Triton X-100/cyclohexane microemulsion can be used as a generic 
environment for the synthesis of MOF nanoparticles.  
In chapter 2, microemulsion synthesis was applied to synthesize ZIFs; the most common 
MOF subclass. ZIF-8 sod was synthesized with a tuneable particle length ranging from 27.3 
to 87.3 nm. This was achieved primarily by adjusting the time taken to add the ligand 
solution to the metal solution. This technique was then applied to synthesize ZIF-67 and Zn-
IM MOFs. A relatively rare Zn(IM)2 neb topology was observed during synthesis.  
In chapter 3, it was demonstrated that microemulsion synthesis could be utilized to 
synthesize the protein complexes BSA@ZIF-8 & BHG@ZIF-8. The resulting materials had 
high loading efficiency values up to ~17%. Furthermore, the particle size could be finely 
tuned from 69.7 to 87.6 nm and 55.9 to 75.3 nm respectively by adjusting the addition time.  
In chapter 4, microemulsion synthesis was extended to UiO-66.  The newly developed 
synthesis is both room temperature and does not require the environmentally harmful use of 
DMF. By altering the addition time or ω0 value the UiO-66 particles size could be altered 
from 4.09 to 31.0 nm. Hence, the synthesis of the smallest sample on record was achieved. 
Finally, in chapter 5, the results of the previous chapters were summarised. It was 
acknowledged that significant room for reaction parameter optimization exists in all chapters 
discussed thus far. However, testing all these parameters would be tedious and may not 
necessarily lead to significant insights. Hence, it was instead proposed that cyro-TEM, 
SAXS and in situ PXRD are used to monitor the growth of a MOF using either, Zn(IM)2 
neb, ZIF-8 or UiO-66. Such a study on the mechanistic behaviour of MOFs synthesized 
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SDS Sodium dodecyl sulphate 
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Chapter 1 -  Introduction 
1.1. Metal-Organic Frameworks 
Metal-organic framework (MOFs) are a subclass of coordination polymers consisting of 
metallic nodes and ligands, arranged to form an extended crystalline lattice (Figure 1.1). In 
MOFs, the metallic nodes are either metal ions or metal ion containing clusters, with multiple 
sites available for ligand binding. The ligands are divergent multi-dentate organic molecules, 
which can have a range of geometries, properties and binding modes.1 MOFs are typically 
porous and possess some of the highest surface areas of any known materials, with several 
structures possessing surface areas of ~7000 m2 g-1. This is approximately the area of an 
American football field packed into a single gram of material.2-4 In addition to their enormous 
surface area, MOFs possess enormous structural diversity with approximately 70,000 
structures identified in the Cambridge Crystallographic Data Centre (CCDC).5 Furthermore, 
MOFs are often highly chemically/thermally stabile due to the combination of strong metal 
ligand bonds and high connectivity.1, 6 The combination of these three properties has allowed 
MOFs to be used in a diverse range of applications (1.1.4 Applications). 
 




MOFs are typically named with an abbreviated name and number code (e.g. HKUST-19, 
NU-100010 etc.) given by their discoverer. There is no consistent naming scheme used by all 
MOFs. In many cases, this name is a reference to the institution that housed the group that 
discovered them e.g. MUF-77 (Massey University Framework).11 Alternatively, the name can 
refer to their structure e.g. ZIF-8 (Zeolitic Imidazole Framework).12 As the naming is left to 
the researchers, ambiguities and inconsistencies are common. For instance, tetramethyl 
substituted MOF-5 is given a new name (IRMOF-18) whereas amine substituted UiO-66 (UiO-
66-NH2) is not.
13, 14 Alternately, a MOF can be identified using an abbreviated chemical 
formula e.g. Zn4(IM)10 (IM= imidazole).
15, 16 However, the use of MOF names is preferred 
because of the existence of structurally different MOFs with the same chemical formula. This 
is discussed further in 1.1.5.1 Topology. In addition to MOF nomenclature, ligands are often 
provided with abbreviated names e.g. H2BDC (1,4-benzene dicarboxylic acid). Unless 
specifically described in this introduction, ligands are referred to by their abbreviation and their 
full names and structures are found in the appendices (Figure C.2). 
1.1.2. History 
One of the earliest coordination polymers was Prussian Blue, which dates to 1706. This 
material consists of CN− ligands and Fe(II/III) ions arranged in a cubic lattice and was an 
inspiration for the development of later coordination polymers. In 1990, Hoskins and Robson 
took inspiration from these materials and proposed that a new class of materials (MOFs) could 
be produced using metal nodes and rod-like ligands. They proposed that these materials would 
have several properties, including: 
1. Significant mechanical and thermal stability due to strength and connectivity of 
metal ligand bonds.  
2. Large cavities which could be evacuated to provide empty pores allowing for a large 
surface area and low density.  
3. A crystalline structure which allows easy resolution using X-ray crystallographic 
techniques. 
4. A highly tuneable pore environment that can be designed through ligand 
modification and which may allow guest uptake, exchange and catalysis.  
5. The ability to be chemically modified after synthesis in order to provide new 
functionality.17    
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Despite earlier syntheses, these predictions were only truly realised in 1999 with the 
independent synthesis of two ground-breaking MOFs: MOF-5 and HKUST-1 (Figure 1.2). 
MOF-5, produced by Yaghi and colleagues, consists of cubically arranged BDC and Zn4O 
tetrads. It was revolutionary, as it displayed stability at temperatures up to 300 oC. Furthermore, 
it retained its structure despite the removal of guest molecules from its pores, a process now 
referred to as activation. It possessed an enormous BET (Brunauer Emmett Teller) surface area 
of 2320 m2 g-1 - the largest surface area of any material known at the time. A later breakthrough 
with MOF-5 was achieved by Yaghi in 2002. They substituted the BDC ligand in MOF-5 with 
a series of ligands with identical coordination sites but different lengths or functional groups. 
This resulted in a series of MOFs with different functional groups on the ligand but the same 
overall topology (1.1.5.1 Topology); known as IRMOFs (isoreticular MOFs). This process of 
substituting the metallic or organic components with analogues that maintain the same 
geometry is known as isoreticular chemistry.13 
HKUST-1 was produced by Williams and colleagues. This MOF consists of Cu2(CO2)4 
paddle-wheel clusters bound to BTC and axial water. Like, MOF-5 it displayed an enormous 
surface area of 1850 m2 g-1. However, they also displayed that water molecules bound to the 
paddle-wheel cluster could be removed through heat treatment. The replacement of axial water 
with pyridine was one of the earliest examples of what later became known as the ‘post 
synthetic modification’ of MOFs. Furthermore, it was found that the removal of axial water 
creates free Cu coordination sites which could be utilised as Lewis acid catalysts highlighting 






Figure 1.2 (A) MOF-5 and (B) HKUST-1 
 Since the achievement of these milestones research conducted in MOF chemistry has 
exploded. To date, a Web of Science search for the term “MOF” will yield 20,978 results and 
will continue to rise as researchers discover new structures and applications.18  
1.1.3. Synthesis Methods 
Typically, MOFs are synthesized using a solvothermal approach where the metal salts and 
protonated ligands (e.g. H2BDC) are mixed with a solvent and heated in an oven. This often 
requires high temperatures (100-200 oC) and long growth periods (several hours to days). The 
solvent is typically N,N′-dimethylformamide (DMF) or N,N′-diethyformamide (DEF), as these 
promote deprotonation of the ligand (e.g. H2BDC to BDC) at elevated temperatures over time. 
As deprotonated ligands sequester metal binding sites, the MOF slowly grows. Solvothermal 
synthesis has aptly been dubbed “shake and bake” chemistry due to the discovery of multiple 
MOF structures by testing various ligand metal combinations and environmental conditions 
with solvothermal methods. 
Unsurprisingly, with the volume of publications in the MOF field, there is enormous 
diversity in the synthetic methods used for synthesis. This is often for the purposes of 
improving yields, scalability, or obtaining specific properties in the resulting products. These 
include electrochemical, room-temperature, microwave, ultrasound and microemulsion 
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syntheses, amongst others. A select few of these are discussed more thoroughly in 1.1.5.2.3 
Morphology Control . 
1.1.4. Applications 
The variety in MOF structures and the ability to tune their pore environments (1.1.5 Crystal 
Design) has resulted in the synthesis of MOFs containing a vast array of different properties, 
including: catalysis19, 20, florescence21, and magnetism.22, 23 Furthermore, the porous nature of 
MOFs allows molecules to defuse into these cavities and interact with the MOF surface. 
Unsurprisingly, the combination of these two properties has allowed MOFs to be utilized in a 
vast array of applications. These include sensors, MRI contrasting agents, membranes, 
photovoltaics, drug delivery, gas storage and catalysis. A select few of the more prominent 
ones are discussed below. 
1.1.4.1. Gas Storage and Separation 
In gas storage applications, surface interactions such as Van der Waals attractions, or 
electrostatic interactions between open metal sites of the MOF host and guest molecules, can 
allow for a higher uptake of gas molecules than the same volume of gas stored in bulk at 
ambient pressures. With climate change becoming an increasing concern, this technique has 
found usage in the high-density storage of sustainable energy sources such as methane and 
hydrogen gas as well as the separation of carbon dioxide.24 In recent years, MOFs that absorb 
water have found applications. These materials are highly sought out for: low energy 
dehumidifiers and providing drinking water from atmospheric condensation for humanitarian 
purposes. For such applications, the MOF must have a high water uptake capacity in arid 
conditions and must be amenable to repeated cycles of water adsorption and desorption. 
Recently, Yaghi’s group tested a MOF-808 (Zr6O4(OH)4(fumarate)6) system outdoors in 
Arizona.* They found that the MOF-808 system had a 25% by weight uptake and could be 
entirely solar driven with adsorption and desorption occurring during night day cycles.† Thus, 
both criteria were fulfilled with a commercially applicable system.25 The commercial viability 
of water absorbent MOFs is further highlighted by a recent start-up company Molecule Ltd., 
which is proposing 2020-21 pilots for desiccation systems based on a proprietary MOF.26, 27 
Along with gas storage, MOFs are also utilized for molecular separations. These include 
noble gas purification28 and separation of CO2 from flue gasses from the post-combustion of 
fossil fuels.29 One approach to molecular separations is size exclusion, which prevents one 
 
* Relative humidity ~30% 
† Night time temperature ~15 oC. Day time temperature ~30 oC 
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material entering the MOF cavity whilst letting the other through. Another approach is via 
selective adsorption, where one material has a higher affinity towards the MOF surface then 
the other.30 A recent example of this approach was for a system separating ethylene and ethane 
mixtures. Ethylene is critical to the synthesis of various polymers and organic molecules. 
However, it is typically produced by thermal cracking of hydrocarbons - a process which 
produces impurities such as ethane. Ethylene is industrially purified using cryogenic 
distillation, an energy inefficient and costly process. In fact, purification of ethylene and 
propylene alone accounts for an estimated 0.3% of the global energy consumption. This is 
approximately the same the energy consumption of Singapore.31 and Last year, our research 
group published an effective MOF that is well able to separate these gas mixtures, MUF-15, 
which consists of Co2+ and benzene 1,3-dicarboxylate (isophthalate). MUF-15 has small pore 
dimensions that maximise Van der Waals interactions between benzene and ethane while 
allowing ethylene through. Hence, MUF-15 is highly efficient at separating these two gasses 
and is capable of purifying 14 L kg-1* ethylene from an equimolar mixture of ethane and 
ethylene.32  
1.1.4.2. Drug Delivery 
Targeted drug delivery is a significant objective of medical research since bioactive 
compounds are often insoluble, or toxic, to otherwise healthy tissue. For instance, the 
chemotherapy drug cisplatin, [Pt(NH3)2Cl2], is highly toxic to proliferating tissues as it 
interferes with DNA synthesis. Hence, patients exhibit side effects including nausea, vomiting, 
anemia, diarrhoea and immunodeficiency. The predominant requirements three predominant 
requirements when designing carriers for drug delivery are listed below.  
1. The carrier should have a high loading efficiency (LE).† However, this must be paired 
with reasonable drug retention to prevent drug leaching on distribution.   
2. The carrier must be transportable to the delivery target and be able to release the drug 
on delivery.  
3. The carrier must have a low toxicity. 33, 34 
For the first criteria, as already noted, the porous cavities of MOFs are excellent 
environments for molecular storage. Indeed, researchers have designed MOF drug complexes 
with incredibly high LE values by entrapping the drug within the MOF pores. At the high end, 
Teplensky and colleagues encapsulated the anticancer drug α-cyano-4-hydroxycinnamic acid 
 
* Litres ethylene per kg MUF-77 per adsorption cycle. 
† Drug mass as a percentage of the total mass. 
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inside NU-1000 with a 68.5 % LE.35 However, the reported LE has substantial variability 
depending on the affinity of the MOF drug pair. This is highlighted by literature indicating LE 
values as low as 1.5%.36  Hence, significant optimization is often required to maximising host-
guest interactions and LE values. Fortunately, the structural tunability and diversity of MOFs 
allows researchers to develop alternate strategies to trap drugs with high LE values. One such 
strategy is to incorporate the drug as part of the MOF through synthesis or PSM. Lin and 
colleagues used this method to obtain 72% for a MOF composed of DCSP 
(cisplatin(succinate)2) ligands and Tb
3+ ions developed using this strategy.37 However, the 
ability to perform this strategy is highly dependent on the drug chemistry.  
For the second criteria, drug release is typically achieved through dissolution of the MOF 
or desorption of the drug in response to stimuli38. To improve retention time and prevent drug 
leaching before delivery, the MOF is often coated in a layer of lipids, silica, or polyvinyl 
propylene (PVP) which improves the MOF stability, drug retention, and biodistribution33, 34. 
Since the coating is typically hydrophilic, it also improves the dispersity of the MOF carrier 
allowing for improved transport. Furthermore, the surface coating can be functionalized to 
improve its affinity for the target. This was demonstrated by Lin’s group who loaded cisplatin 
into the MOF NCP-1 coated with silica. The silica surface coating was then functionalized with 
a peptide chain that had a high affinity for receptor proteins common in cancer cells. Receptor 
binding triggers uptake of the MOF carrier. NCP-1@silica releases cisplatin after 5-9 hours 
due to degradation in physiological conditions (pH 7.4, 37 oC). The authors postulated that this 
time delay is sufficient to allow deposition in tumour cells, due to its targeted delivery37. This 
is considered active delivery because the target is selected through chemical recognition. 
Alternatively, passive delivery can occur and is where distribution is nonspecific. In such cases, 
environmentally induced drug release is typically the targeting mechanism. One such 
mechanism was proposed by Sun and colleagues in 2012. They proposed using ZIF-8 to deliver 
the anticancer drug 5-fluorouracil on the basis that cancer cells possess an acidic environment 
(pH 5.5 – 6). ZIF-8 degrades in acidic conditions (pH >6), thus releasing the drug39. Since this 
study ZIF-8 has regularly been used as a passive pH sensitive carrier40-42. Whilst these 
approaches are promising distribution of nanocarriers within a living organism is complex. The 
shape and size of a carrier can critically affect its overall distribution. For instance, carriers less 
than 150 nm in diameter are more likely to be delivered to the cellular interior by endocytosis43, 
44. Though, larger carriers have been demonstrated to enter by this mechanism depending on 
the shape. This can impact their likelihood of reaching the target site. For instance, NPs less 
than 200 nm in length tend to accumulate at tumour cells by travelling through the leaky 
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endothelium. Furthermore, even the path by which NPs are filtered out of the body is size-
dependent as 200 nm particles have been demonstrated to be filtered through the spleen, but 
NPs less than 10 nm traverse the kidney. Our current inability to precisely control the shape 
and size of MOF crystals and our lack of understanding of the overall impact of these factors 
on their biodistribution are severe limitation on the real-world usage of these materials33, 34, 45. 
Studies on MOF carrier toxicity are equally promising. Common drug delivery MOFs, 
include low cytotoxicity ligands (BDC, BTC imidazole) and metals (e.g. Cu2+, Zn2+, Fe2+, 
Fe3+)33 and have displayed limited cytotoxicity in vitro. One such study by Hoop and colleagues 
concluded ZIF-8 had limited cytotoxic effects on kidney, skin, breast, blood, bones, and 
connective tissues46. In vivo, multiple studies have demonstrated the use of these materials is 
biocompatible in mice47-49. Unfortunately, limited information is available about the safety of 
these materials in vivo in humans. Currently only the University of Chicago and RiMO 
Therapeutics Inc. are conducting any human trials. Furthermore, this is only in phase I and is 
expected to last until March 2021 before phase II and III trials can even begin50, 51.      
1.1.4.3. Catalysis 
MOFs have many properties that endear them towards catalytic applications. They are a 
solid material and can be easily extracted and recycled as heterogenous catalysts. Their diverse 
and tuneable pore environments allow the introduction of catalytic sites in the form of open 
metal sites19 or as part of the ligand.52, 53 Therefore, these can be used in a wide array of catalytic 
applications, including CO2 reduction
54 and nerve gas degradation.55, 56 By introducing multiple 
catalytic sites, MOFs can perform tandem catalytic processes.57 Furthermore, the catalytic 
viability of MOFs is further enhanced by its large surface area and porous nature, which allows 
a high density of catalytic sites to be exposed to reactants migrating through their pores.  Hence, 
they are often highly effective catalysts.52, 53  
In addition to high catalytic efficiency and a diverse range of catalytic functionality, by 
tuning the shape of the pore environment or the size of the pore aperture, MOF catalysts can 
be imparted with size or shape selectivity towards products or reactants.58, 59 This is highlighted 
by a 2018 study by Farha’s group., in which they used UiO-66-Ir(II) to catalyse the borylation 
of methane to monoborylated methane, instead of its thermodynamically preferred diborylated 
methane. The monoborylated variant has a length of 0.88 nm whereas the diborylated variant 
has a length of 1.39 nm. As the pore width of UiO-66-Ir(II) is 1.1 nm, the smaller 
monoborylated product is selectively synthesized.20  
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1.1.5. Crystal Design  
This diversity in MOF structure function and applications arises largely from their tuneable 
nature.  Instead of selecting an application based on the properties of a material, MOFs have 
the potential to have the material properties selected to suit the specific application. For this 
reason, some researchers have referred to them as potential designer materials. Whilst 
significant progress has been made to this affect, the development of new methods to tune MOF 
properties is still a significant area of ongoing research.  
1.1.5.1.Topology  
Whilst isoreticular synthesis and PSM focus predominantly on maintaining the underlying 
connectivity while altering the functionality of the MOF, in many instances it is desirable to 
alter the underlying connectivity and pore structure. This can influence selectivity, stability and 
guest adsorption behaviour. The underlying arrangement of the atoms within the crystal is 
known as the topology.60  
MOF topologies are described using nets. A net is a graph of vertices connected by uni-
directed edges where all vertices/edges are connected.61 To represent a MOF as a net, a repeated 
substructure within the MOF, known as a secondary building unit (SBU), is represented as 
either an edge or vertex and abstracted to a net of the MOF’s overall structure (Figure 1.3). 
Known nets are recorded in databases such as the Reticular Chemistry Structure Resource 
(RCSR) database. The RCSR database identifies nets using lower-case bold three letter codes 
e.g. dia.62* By selecting SBUs with specific geometries, the topology can often be rationally 
designed. For instance, the combination of an octahedral cluster and linear ligand will most 
likely form a pcu net.63 
 
* It should be noted that suffixed codes such as dia-c exist. However, these do not appear within the scope of 
this thesis. Such codes occur where the unit cell symmetry may differ but the tiling remains the same. E.g an 




Figure 1.3 (A) Example RCSR nets. (B) Abstraction of MOF-5 to a pcu net. 
Unfortunately, the resulting topology cannot always be rationally inferred from the 
structure of the starting materials. The formation and growth of MOFs is a nuanced process 
often involving several intermediates. As a result, the product’s topology is often highly 
sensitive to specific reaction conditions. Studies have demonstrated that topological changes 
will occur because of changes to the temperature, metal salt selection, solvent, and multiple 
other conditions. This was highlighted by Nakamura and colleagues. when they demonstrated 
that Zn(NO3)2.6H2O and H2BDC could alternatively form MOF-2 (2D sheets) or MOF-5 (pcu) 
solely due to a 25 oC temperature difference during solvothermal synthesis. In Nakamura’s 
case, this was attributed to the formation of a Zn2(CO2)4(H2O)2 paddle wheel cluster during the 
lower temperature synthesis. Thus, 2D sheets of MOF-2 were formed in place of MOF-5 due 
to the differing SBU geometry.64 
This topological dependence on the reaction environment is further complicated by the 
existence of topoisomers. A topoisomer is where two structures consist of components with the 
same geometry but have different overall topologies. This is highlighted by NU-1000 (csq) and 
NU-901 (scu), which both possess the same zirconium cluster and 1,3,6,8-tetrakis(p-benzoic 
acid)pyrene ligand, but different topologies (Figure 1.4). The task of elucidating the influence 
of different synthetic conditions on such structures is non-trivial, with slight synthetic changes 
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resulting in significant topological changes. For instance, the substitution of benzoic acid with 
4-aminobenzoic acid will result in NU-901 being synthesized instead of NU-1000. For this 
reason, topological control of MOF formation is still a major field of ongoing of research.65  
 
Figure 1.4 NU-1000 csq and NU-901 scu synthesis derived from the same hexanuclear 
Zr(IV) SBUs.  
1.1.5.2. Morphology 
Morphology refers to the overall form of the crystal i.e. its size, shape and dispersity (size 
range) (Figure 1.5). Whilst it is predominantly influenced by the topology, MOF morphology 
is highly sensitive to the reaction conditions, can change during the MOF synthesis and is 
difficult to precisely control (1.1.5.2.3 Morphology Control ). Furthermore, the morphology 
can have a drastic impact on the properties and usage of a MOF. For instance, the MOF 
morphology influences the packing of the MOF with itself or other materials. This influences 
the adsorption profile by changing the volume of interstitial voids between crystals.66 It can 
even impact the integration of MOFs into membranes or the properties of composite 
complexes.67-69 An example of this was highlighted by Avci and colleagues. They synthesized 
arrays of ZIF-8 particles which reflected light of specific wavelengths. By changing the particle 




Figure 1.5 Cubic morphology of MOF-5 
1.1.5.2.1. Nanoscaling  
A significant objective in morphological control studies is to synthesize sub-100 nm MOF 
nanoparticles (NPs). These materials are highly valued because they can exhibit properties not 
typically seen in the bulk material. For instance, they can be dispersed in solvents as colloids, 
allowing them to be more readily used in solution phase applications. Furthermore, their 
reduced dimensions influence their accelerated adsorption and diffusion kinetics. This is 
advantageous in catalytic applications, as it allows faster introduction of reactants to catalytic 
sites. This was highlighted by Wang and colleagues. in 2017. They synthesized 40 nm, 850 nm 
and 1.5 μm ZIF-8 particles containing platinum NPs (Pt@ZIF-8) and utilized them for the 
hydrogenation of hexene. They found that the amount of hexene converted to hexane over a 2 
hour period decreased substantially from 95.3% (40 nm) to 7.6% (1.5 μm) as the size 
increased.68. In addition, precise morphology control of NPs is essential for controlled in vitro 
distribution (1.1.4.2 Drug Delivery). It is important to note, when evaluating NP synthesis 
techniques, that the dispersity is often as critical in its application as the average size. There is 
no consistent standard used in the MOF literature for reporting the NP size and dispersity. A 
review by Marshall and colleagues recommended that future studies report the average NP size 
(ϕ), standard deviation (SD) and the sample size. This was used as the reporting standard for 
this thesis.71 In the literature the dispersity* is also often reported as the polydispersity index 
(PDI) (eq. 1.1) or relative standard deviation (RSD) (eq. 1.2). A PDI of 0.05 (RSD 22.4%) is 
generally considered useable for calibration standards. Whereas, a PDI of 0.2 is generally 
deemed acceptable for drug delivery (RSD 44.7%).72 Given the majority of MOF NPs where 
 
* Particle size range within a single sample 
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dispersity data is published fall into this later bracket,71 an RSD of less than 45% was taken as 
reasonably monodispersed in the context of this thesis.  





    
1.2 𝐑𝐒𝐃 =   
𝐒𝐃
𝛟
∗ 𝟏𝟎𝟎   
1.1.5.2.2. MOF Formation 
The topic of this thesis is an evaluation of a specific MOF morphology control technique 
(1.2.1 Microemulsion Synthesis). For this purpose, knowledge of crystal formation 
mechanisms is required to understand the rationale behind this and similar techniques. 
Unfortunately, the current understanding of MOF formation is far from complete and is beyond 
the scope of this study. For this reason, a brief overview of crystal formation as it pertains to 
MOF formation is provided in this section.  
In the 1950s, LaMer proposed the model of burst nucleation to describe crystal formation, 
which is considered the basis for scientific understanding of crystal formation. It proposes that 
in a supersaturated (CS) solution of precursors crystal formation occurs in two separate steps 
that deplete precursors from the solvent; nucleation and crystal growth (Figure 1.6). During the 
nucleation phase, initial solid seed crystals are developed from a supersaturated solution of 
precursors. The Gibb’s free energy of nucleation (ΔG) is the sum of two opposing contributions 
(eq. 1.3). The favourable contribution is the Gibb’s energy lost due to increasing the non-
interfacial bulk volume. It is dependent on the energy difference between the solid crystal phase 
and the solvent phase (Δg). The unfavourable contribution is the energy gain due to increasing 
the interfacial free energy. It is dependent on the interfacial surface energy (γ) which in turn is 
a function of the external surface area of the developing crystal.  
1.3 𝚫𝑮 = 𝟒𝝅𝒓𝟐𝛄 −
𝟒𝝅
𝟑




Figure 1.6 MOF Precursors nucleate forming seed crystals  which agglomerate and sequester 
MOF precursors for further crystal growth. 
Both contributions are a product of the nuclei radius (r) to differing powers. Hence, until a 
critical nucleus radius (rc) (eq. 1.4) is obtained, crystal dissolution to regenerate the precursors 
is favoured. Hence there is an energy barrier (ΔGA) (eq. 1.5) that must be overcome for 









𝒓𝒄𝚫𝒈)   
However, this model of nucleation assumes homogenous nucleation. In actuality, 
nucleation predominantly occurs on pre-existing surfaces, such as the container walls or 
adventitious debris (heterogenous nucleation). This reduces the interfacial free energy of the 
growing crystal, thus reducing the activation barrier. Hence, the nucleation rate is significantly 
influenced by the availability and composition of heterogenous nucleation sites and it 
employed to good effect in laboratory processes such as scratching the interior of a 
crystallisation vessel with a glass rod.73 The importance of this process in nucleation has 
extensively been studied with water. Whilst the melting point is 0 oC the freezing point and 
nucleation rate can vary significant depending on the available nucleation sites.74 In a 2008 
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study by Zobrist and colleagues, a 20 oC difference in freezing temperature was observed using 
4 different nucleating materials (nonadecanol, silica, silver iodide and Arizona test dust).75  
During the crystal growth phase, crystal growth occurs as a result of several processes 
driven by the favoured increase in bulk crystal size. These include sequestration of precursors 
onto the nuclei surface, aggregation of pre-existing seed crystals, and Ostwald ripening. 
Ostwald ripening is the process where unstable or meta-stable prenucleation crystals are 
dissolved back into the solution for their precursors to be redeposited onto larger crystals.76  
Generally, the crystal size is modifiable by altering the nucleation and growth rates. As the 
nucleation rate is increased more seed-crystals are produced and a shorter growth period is 
required before growth is terminated. Hence, smaller crystals are obtained. Early termination 
of the growth period will also result in smaller crystals. Whilst the LaMer model is the primary 
model used to describe crystal growth and develop morphological control techniques, it is often 
insufficient to fully describe the complex growth behaviour of MOFs.71, 76 An example of this 
can be seen with ZIF-8 which increases in NP size as the reactant concentration increases. This 
is counterintuitive using the LaMer model which predicts faster nucleation due to increased 
concentration. This result was attributed to the formation of intermediates during the nucleation 
process. Amorphous intermediates are re-dissolved as part of its nucleation process, slowing 
nucleation.77 
The crystal shape is primarily dependent on the topology. The crystal topology determines 
which crystal facets are exposed to the outer surface. Hence, growth along different crystal 
facets occurs at different rates dependent on the topology. However, the growth rate along a 
facet is also dependent on the concentration of reactants/intermediates present in the solution. 
Due to the variability of this over time, the shape evolves as crystal growth proceeds. The 
thermodynamic equilibrium shape is defined by the slowest growing facet (Wulff’s rule).78 For 
instance, HKUST-1 has competitive growth along two faces [100] and [111]. Hence, HKUST-
1 typically possess an octahedral, cuboctahedral or cubic morphology (Figure 1.7). Faster 
growth along the [111] facet will favour a cubic morphology whereas octahedral crystals are 






Figure 1.7 From left to right: common HKUST-1 morphologies octahedral, cuboctahedral, 
and cubic morphologies. 
1.1.5.2.3. Morphology Control  
Controlling crystal morphology is an ongoing challenge in MOF chemistry. This 
particularly applies to the production of NMOFs. Whilst significant progress has been made in 
their production, less than 100 structures have been prepared at the nanoscale. Furthermore, 
structures with crystals less than 20 nm in size are particularly rare. Researchers have 
developed several strategies for morphology control including interfacial synthesis, 
modulation, etching and templating. However, many of these focus on the production of 2D 
layers and macrostructures, which is not the focus of this thesis. Only a few techniques have 
found significant usage for MOF NP synthesis: reaction optimization, microwave (MW) & 
ultrasound (US) synthesis, modulation and microemulsion synthesis.   
During MOF synthesis, many different reaction parameters can be tuned to modify the 
morphology. These include, the reactant concentration, temperature, metal to ligand ratio, and 
the choice of metal salts etc. For instance, Schejn and colleagues. found that the size of ZIF-8 
crystals could be varied from 50 nm to 600 nm simply by substituting the Zn2+ salt. More 
reactive salts such as Zn(NO2)2 tended to produce smaller crystals than less reactive salts such 
as ZnCl2.
80 Unfortunately, this approach is far from generically applicable. For instance, ZIF-
8 and UiO-66 have both been demonstrated to reduce in NP size as the ligand metal ratio 
increased.81, 82 This is because the excess ligands occupy all available metal binding sites faster, 
increasing the nucleation rate. However, even this cannot be universally applied. HKUST-1 
produced with excess BTC has been demonstrated to increase the NP size.83 Because of these 
often-contradictory results, rigorous optimization of synthetic protocols is often required to 
obtain a desired morphology. Hence, high throughput screening or repetitive trial synthesize 
are used to compile comprehensive literature on their morphological behaviour.81, 82, 84 
However, such an approach is time consuming, costly, and inefficient. 
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A more generically applicable method to modify the MOF morphology is to alter the 
heating conditions using microwave (MW) or ultrasound (US) synthesis. These methods 
produce local hot spots throughout the solution promoting fast energy transfer and homogenous 
nucleation.85 Therefore, these methods typically possess faster nucleation and crystal growth 
rates. This was highlighted by Haque and colleagues, who compared the nucleation and growth 
rate of conventional heating with US/MW methods for MIL-53. They found that both the 
nucleation and growth rate followed the same general trend; US proceeded faster than MW, 
which in turn was significantly faster than conventional heating.86 Unsurprisingly, the 
increased nucleation and growth rates allows the production of smaller crystals and shortens 
the synthetic time. This reduction in synthetic time was observed in the first MW MOF 
synthesis of Cr-MIL-100 by Jhung, Lee, and Chang in 2005. The synthetic time was reduced 
from 4 days with conventional heating to 4 hours by MW synthesis.87 Later reports demonstrate 
synthetic times of an hour or less. As to the impact on particle size, comparative syntheses of 
the same MOFs using MW/US and conventional heating highlights that the size decreases as 
the nucleation and growth rates increase. This is demonstrated with MIL-53, which was 
synthesized using conventional heating (5-25 μm), MW (1-2 μm) and US (400-800 nm).86 
Furthermore, the particle size is often adjustable by altering the reaction time or power 
output.88, 89 Whilst this provides a promising route toward tuneable NMOF synthesis, in 
practice, MW/US syntheses often have reproducibility issues because of different reaction 
apparatus/setups that are difficult to control for. In addition, increased power output can result 
in increased dispersity (reduced uniformity) and amorphization of the product. 
Further limitations of MW/UW synthesis are seen in its size range, scalability and power 
output. Whilst particle size is often reduced by using these techniques, the production of 
NMOFs below 100 nm in diameter is rare. Where NMOFs have been synthesized, MW/US 
synthesis is often used in combination with reaction optimization or modulation to achieve the 
desired morphology. In addition, scale-up of MW synthesis is generally regarded as a 
significant challenge due to limited penetrated depth of energy supply in a bulk solution. 
Finally, it should be noted that in some cases, delicate molecules are incorporated into the 
MOF, such as proteins, drugs and thermally sensitive ligands. In such cases, MW/US synthesis 
is unsuitable (Chapter 3 - In situ Protein Encapsulation in Microemulsions).  
In 2009, Kitagawa’s group proposed that the size and morphology of MOF crystals could 
be tuned by adding a monodentate ligand (which is not incorporated into the MOF) into the 
reaction mixture.59 This method, known as modulation, controls particle growth by two 
mechanisms. The first is pH modulation, where the modulator changes the rate of ligand 
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deprotonation. A basic modulator will deprotonate the ligand allowing for enhanced ligand 
metal coordination. For this reason, triethylamine is used in the synthesis of ZIF-8, and MOF-
5 NMOFs. The other mechanism is coordination modulation, where modulators compete for 
metal sites with the ligands and temporarily substitute them by coordinating available sites. 
Hence, increased modulator concentration slows the growth and nucleation rates allowing for 
larger crystals to be formed.71  
A variant of modulation, known as surfactant assisted synthesis, uses a surfactant in place 
of standard modulators. A surfactant is an amphiphilic molecule with a long hydrophobic tail 
and a polar head group. Different crystal facets have different binding energies. Therefore, 
surfactants added to the solution will preferentially bind specific facets, slowing the growth 
along that facet by competing with ligand binding. This was first demonstrated by Ma and 
colleagues in 2011 to synthesize IRMOF-1, 2 and 3 with Cetrimonium bromide (CTAB)90. 
Another early example of this technique for shape control was by Kitagawa’s group. in 2011. 
They modified the morphology of HKUST-1 in a stepwise fashion from octahedral to 
cuboctahedral to cubic. This was achieved by adding increasing amounts of dodecanoic acid, 
which preferentially binds the <100> face.79  In addition to shape control, surfactant assisted 
synthesis can be utilized to modify the particle size. This is demonstrated by Pan and 
colleagues, who increased the length of ZIF-8 particles from 100 nm to 4 μm by decreasing the 
concentration of CTAB.91 Furthermore, surfactant assisted synthesis often produces colloidal 
MOFs with low dispersity (high uniformity). This was best demonstrated by Avci and 
colleagues in 2017, with the synthesis of ZIF-8, UiO-66 and MOF-5. These syntheses were 
remarkable because they displayed high uniformity in both shape and size* which allowed the 
crystals to be arranged into packed layers with long-ranged ordering. Furthermore, the length 
of ZIF-8 crystals could be tuned from 178 to 227 nm. However, this size tuning was due to 
optimizing the ligand and CTAB concentration and could not be generalized to other 
syntheses.70 However, this approach highlights how surfactant assisted synthesis could be used 
in tandem with other approaches to produce highly uniform, tuneable MOF NPs.   
Despite continuing research into various methods for MOF morphology control, to date, 
no existing method offers facile, tuneable, synthesis of uniform MOF NPs. For this reason, 
continued investigation into new morphology control techniques or more comprehensive 
investigations of the factors influencing MOF morphology are required before MOF with 
specific morphologies can be designed without extensive reaction optimization. Herein, a 
 
* 5% standard error in particle length 
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relatively novel technique (microemulsion synthesis) is investigated to determine its effects on 
MOF morphology.     
1.2. Microemulsions 
Microemulsions are transparent, thermodynamically stable, colloidal mixtures of two 
immiscible liquids. The most common colloidal mixture is formed from hydrocarbons and 
water where small particles of one phase become suspended in the other. They were first 
documented in the scientific literature by Hoar and Schulman in 1943.92 Because of this long 
history, microemulsions have been well documented in a series of books. These results are used 
to provide a general overview of microemulsion in this section.93, 94 
Microemulsions are generally stabilized with a surfactant which is typically arranged at the 
interface between the two phases, though this is not always the case.95 Surfactants are often 
referred to by their head group charge e.g. cationic, anionic, non-ionic or zwitterionic. Whilst 
similar to typical emulsions, microemulsions are distinguished by having an incredibly low 
interfacial surface tension. Typically, this is achieved by the addition of a cosurfactant; 
typically an alcohol with a short carbon chain. The cosurfactant is weakly amphiphilic and 
perforates the oil-water interface spacing surfactant molecules and reduces intermolecular 
repulsion between surfactant head groups. However, microemulsions have also been produced 
without a cosurfactant. This has been achieved by using surfactants with multiple tail groups 
such as dioctyl sodium sulfosuccinate (AOT)96, where the second tail substitutes the 
cosurfactant’s role. Alternatively, cosurfactant free microemulsions have also been made by 
using non-ionic surfactants, such as Tween-80.97 This is presumably due to the reduction of 
intermolecular repulsion between that is expected for charged head groups.  
As a result of the low interfacial tension, microemulsions are thermodynamically stable, 
optical transparent, and have a low viscosity. The thermodynamic stability of an emulsion is 
determined by the Gibb’s free energy of formation (eq. 1.6). The dispersion of both phases 
causes a favourable increase in enthalpy (ΔS) but brings about an unfavourable increase in the 
interfacial surface area (ΔA). In a microemulsion, the surface tension (γ) is sufficiently low 
such that γΔA outweighs ΔS. Hence, microemulsion formation is thermodynamically favoured 
and spontaneous. For typical emulsions, the Gibb’s free energy is positive. Hence, energy must 
be supplied to stabilize the emulsion through stirring otherwise agglomeration of the dispersed 
phase and phase separation occur.98  
1.6  𝚫𝑮 = 𝜸𝚫𝑨 − 𝚫𝑺    
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Microemulsions are broadly classified as oil in water (o/w), water in oil (w/o), or 
bicontinuous microemulsions (Figure 1.9); historically denoted Windsor I-III*. Oil in water 
(o/w) microemulsions consist of an excess of the hydrophilic phase with the hydrophobic phase 
dispersed in micelles. For bicontinuous microemulsions, both the oil and water exist as a 
continuous phase dispersed throughout the microemulsion, like a sponge. In w/o 
microemulsions, the structure is inversed from the w/o variant. The micelles entrap the aqueous 
phase with the polar head groups facing inwards. These are often called reverse micelles though 
this term has been inconsistently used in the literature. Some proponents instead opt for reverse 
micelles to only refer to these structures when they contain no free water. e.g. all water 
molecules in the micelle are bound to the surfactant water interface.  
  
 
* Other microemulsion structures exist such as surfactant free microemulsions. Most notably, ionic liquid (IL) 
microemulsion substituting the hydrophobic/hydrophilic phases with an IL (IL/o or w/IL) have become 





Figure 1.8 Generic volume ratio of emulsion components and the resulting 
microemulsion phases. 
In addition to the ratio of different components, the microemulsion structure is also 
influenced by other factors such as the solvent, temperature, dispersant and the presence of 
salts. Two surfactant properties play a significant role in the formation of micellular structures: 
the hydrophobic lipophobic balance (HLB) and the critical packing parameter (cpp). The HLB 
is typically defined using eq. 1.7. In this definition each hydrophilic and lipophilic group is 
assigned a value (ch & cl). The HLB is a function of the sum of the contribution of each 
hydrophilic function group minus the contribution of each lipophilic group. 
1.7  𝐇𝐋𝐁 = 𝟕 + ∑ 𝒄𝒉 − ∑ 𝒄𝒍    
The cpp is described by eq. 1.8 with the surfactant volume (v), the head group area (ah) and 
the length of the tail group (lt).  
1.8  𝐜𝐩𝐩 =
𝒗
𝒂𝒉𝒍𝒕
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Generally, a smaller cpp parameter and larger HLB favour the formation of o/w 
microemulsions over water in oil microemulsions. These properties can also influence the 
shape of micellular structures. For instance, a cpp value of less than 0.33 would imply a 
spherical micelle whereas rod-like or hexagonal structures are more prevalent at cpp values 
between 0.33 and 0.5.99    
The focus of this thesis is on w/o microemulsions because these are extensively used for 
morphology control of inorganic nanoparticles and to date are the only microemulsions utilized 
for MOF synthesis. For the sake of brevity, the term microemulsion or micelle will be referring 
specifically to w/o microemulsions and reverse micelles, unless otherwise stated.   
1.2.1. Microemulsion Synthesis  
One application of microemulsions is as a template for the synthesis of monodispersed 
nanoparticles. This was first achieved by Boutonnet and colleagues in 1982, with the synthesis 
of Pt, Pd, Rh, & Ir nanoparticles100. Since then microemulsion synthesis has been extensively 
utilized to synthesize metal nanoparticles, core-shell materials, semiconducting quantum dots 
and silica nanoparticles.  
Microemulsion synthesis, is a templated precipitation technique where a precipitating agent 
is introduced to the material precursors within the micelles’ confined aqueous phase. For metal 
nanoparticle synthesis, the precursors are a metal salt and a reducing agent e.g. (NaBH4, NaOH) 
used to induce precipitation. The precipitating agent is introduced either as an aqueous solution 
(single microemulsion method) or as the aqueous phase of a separate microemulsion (two 
microemulsion method) (Figure 1.9). The nucleation and growth kinetics of nanoparticles 
within microemulsions is dependent on two factors, the reaction rate and the micellular 
kinetics. Micelles travel through the solvent and collide due to Brownian motion. On collision, 
temporary dimers are formed which last between 10 μs and 1 ms before splitting apart. The 
formation of dimers allows for exchange of the components inside the micelles, inducing 




Figure 1.9 Generic microemulsion synthesis using the two-emulsion protocol. 
Initially, it was thought that the primary influence on particle morphology was the 
morphology of the micellular template. Indeed, this templating effect does play a significant 
role. In 2005, Li and collegues. proposed a templating mechanism where nucleation occurs at 
the surfactant water interface and particles grow inwards mimicking the microemulsion shape 
and size. This was after they observed ZnSe hollow spheres evolving into 200-300 nm 
nanospheres using transmission electron microscopy (TEM)103. This result is consistent with 
several studies reporting the growth of hollow spheres using microemulsion synthesis. 
However, it is still unclear why this inward growth occurred. Eastoe proposed that since the 
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reaction rate was significantly faster than the coalescence rate, nucleation was induced at the 
micellular interface immediately on coalescence.101 However, this is unconvincing given that 
heterogenous nucleation on the micellular interface also seems sufficient to explain this 
observation.  
Considering that templation effects have long been considered the primary mechanism for 
size control, many researchers have attempted to control particle morphology by altering the 
template morphology. For this reason, extensive research has gone into tuning the particle size 
by adjusting the water/surfactant ratio, ω0 (eq. 1.9). The ω0 value is related to the micelle size 
by eq. 1.10, where d is the micelle diameter, SA is the surfactant surface area and V is the 
aqueous volume. By increasing the water volume, the micelle size increases. Thus, the particle 
size of the final nanomaterial also increases.   
1.9  𝝎𝟎 =
[𝒘𝒂𝒕𝒆𝒓]
[𝒔𝒖𝒓𝒇𝒂𝒄𝒕𝒂𝒏𝒕]




    
Whilst many studies have utilized this approach successfully to tune the particle size, it is 
not generically applicable, and several studies have observed no correlation between ω0 and 
the resulting particle size.101 This has led to the conclusion that the particle morphology is more 
nuanced then initially expected. For instance, microemulsion dimensions are not only 
influenced by ω0. The presence of cosurfactants, the surfactant chemistry, temperature and the 
aqueous composition all play a considerable role. Calandra and colleagues highlighted this 
effect by synthesizing AOT microemulsions containing aqueous AgNO3 and AgCl. Both 
microemulsions possessed a larger micellular diameter and greater polydispersity then the 
equivalent microemulsion containing pure water104.  
Furthermore, the particle morphology is not solely dictated by templating effects. Multiple 
studies report the synthesis of NPs significantly larger or smaller than the micellular template, 
in contradiction with a templating model. These observations are often rationalized with the 
concept of interfacial fluidity. Interfacial fluidity is the bending modulus of the interfacial 
surfactant layer and denotes the layer’s rigidity. The interfacial fluidity is primarily dependent 
on the surfactant layer’s packing parameter. Denser packing results in a less fluid interface. 
Hence, longer tail groups with stronger Van der Waals interactions will produce a more rigid 
interface, whereas the use of ionic head groups will increase interfacial fluidity due to 
repulsion. The more fluid the interface is the faster the rate of intermicellar exchange. However, 
membrane fluidity also increases the likelihood of micelle agglomeration as the particle grows. 
101, 102   
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The impact of interfacial fluidity and the complexity of growth mechanics in 
microemulsion systems was recently highlighted by a mechanistic study by Sunaina and 
collegues.105 They studied the growth of copper oxalate within a water/iso-octane 
microemulsion using CTAB as the surfactant (Figure 1.10). They used 1-octanol and 1-butanol 
as cosurfactants. The longer chain of 1-octanol significantly reduced the interfacial fluidity. In 
both microemulsions growth occurred in a two-stage process. The first stage was growth within 
the microemulsion until the microemulsion was fully occupied. In both cases, the product 
collected after this stage was spherical. However, due to the reduced interfacial fluidity of the 
1-octanol microemulsion this process took 7-hours instead of the 1-2 hours required for 1-
butanol. This was attributed to the slowed exchange rate. In the second stage, the 
microemulsion and NPs expanded in tandem. For the 1-butanol microemulsion, the final 
product was elongated up to 74.5 nm in length. This was attributed to the denser packing of the 
1-butanol surfactant distorting the initial microemulsion into an ellipsoid. The surfactant 
molecules along the NP were bound to the NP surface. Whereas an unbound domain existed at 
both ends of the NP, where micellular exchange was able to continue. No mechanism was 
provided for the synthesis of the cube-like NPs formed with 1-butanol.105 This is indicative of 
the further work needed to fully elucidate the mechanisms of growth control during 
microemulsion synthesis.  
 
Figure 1.10 Copper oxalate growth schematic in CTAB/alcohol w/o microemulsion using 
(A) 1-butanol and (B) 1-octanol as the cosurfactant. 
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1.3. Microemulsion MOF Synthesis 
To date, literature in the field of microemulsion synthesis of MOFs is a miniscule subset 
of the overall work in either the MOF or microemulsion fields (Table 1.1). The application of 
microemulsion synthesis to MOF chemistry was first achieved by Lin’s group in 2006. They 
synthesized Gd(BDC)1.5 rods (BDC = 1,4 benzene dicarboxylate) with a length of 100-125 nm 
and 1-2 μm within a CTAB w/o microemulsion for use as MRI contrasting agents.106 Since this 
initial work, several studies have been conducted on microemulsion synthesis of MOFs. As a 
subset of the microemulsion field, these studies are at least representative of some of the more 
commonly used surfactant systems. Triton X-100, CTAB and AOT are highly prevalent non-
ionic, cationic, and anionic surfactants, respectively. Furthermore, there is some coverage of 
different addition strategies. Most of these studies used a two microemulsion approach whereby 
the ligand and metal are initially confined to different microemulsions (denoted herein as μEL 
and μEM). In all cases, μEL was then added to the μEM. Alternatively, Xia and colleagues 
used a single emulsion approach to synthesize EuxTbx-1(oxalate)(fumarate). Here, an aqueous 
solution containing the ligands was added to the metal containing microemulsion. Another 
unique approach was by Melindandri’s group. They used a three microemulsion method to 
synthesize a series of zinc(II) and copper(II) carboxylate MOFs. μEL was first added to μEM. 





Table 1.1 Microemulsion Synthesized MOFs* 
 
Unfortunately, these studies represent a very limited subset of the of the diverse MOF 
structures available. Despite the stunning structural diversity in the MOF literature, all but two 
microemulsion studies use one of three ligands: 2-methylimidazole (mIM), terephthalic acid 
(BDC) and trimesic acid (BTC). The two exceptions are the studies conducted by Xia and 
Melindandri. Xia and colleagues synthesized EuxTbx-1(oxalate)(fumarate) by incorporating two 
ligands oxalate and fumurate. Melindandri’s group incorporated a series of CnCOOH ligands 
 
* A study referring to ultrasound assisted reverse micelle synthesis were explicitly excluded. This is because the 
technique only involves one solvent phase despite using the misleading term reverse micelle.107  
† Morphology 
‡ References 
§ZIF-8 and ZIF-8 complexed with horseradish peroxidase. 
**Several samples were produced with differing morphologies.  
†† Synthesized series of zinc and copper carboxylate MOFs  
‡‡ Oxalate and fumurate 
Surfactants MOF Ligand Metal Length  Morph.†  Ref.‡ 
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into MOFs denoted as Cu/Zn NCPs. Given the limited array of available MOFs, further 
screening of different MOFs that can be synthesized using this technique is highly valuable.   
From the limited existing literature there is promise that microemulsion syntheses can 
produce MOF NPs. Except for Xia and colleagues, all studies managed to produce MOF NPs 
with a length less than 100 nm. However, the objective of MOF NP synthesis is not solely to 
produce incrementally smaller MOFs. The dispersity and tuneability of the product are critical 
parameters to consider when selecting a synthetic technique. Unfortunately, the MOF literature 
is inconsistent when reporting the dispersity. Of the microemulsion MOFs, this has only been 
reported in three cases. The most extensive analysis of NP dispersity was performed by 
Hatakeyama and colleagues on Gd MOFs. They found that across 28 samples the RSD in length 
varied from 19 to 50 %.102 Sun and colleagues synthesis of ZIF-8 and ZIF-67 reported an 
improved RSD of 17 and 18 %.112 Melindandri’s group reported RSD values between 24 and 
30 % across 4 samples.115  
As to the tuneability, several studies do not report any attempt to tune the particle size or 
shape at all or test only sporadic conditions.112, 108, 110, 113. This is highlighted by Zheng and 
colleagues. They added ethanol into the reaction mix for the synthesis of HKUST-1 in a TX-
100/hexanol microemulsion system. The resulting crystals were more uniform and smaller than 
their counterpart synthesized without ethanol. However, with only two samples it is difficult to 
gauge the actual effect ethanol had on the microemulsion or HKUST-1 growth. Of the studies 
that place focus on systematic synthesis, ωo is generally the only factor investigated. Whilst a 
strong correlation is observed between ωo and the NP size in all cases,109, 106, 114 the small subset 
of structures makes it unlikely this would hold true in later studies. Hatakeyama’s 2011 study 
is the most comprehensive on the record. It explores both ωo and the addition of three different 
amphiphilic additives used to change the interfacial tension of the microemulsion. They 
attempted to synthesize Gd BTC and Gd BDC. Interestingly, in all cases, an increase of ωo 
resulted in an increased NP size. However, the addition of sodium salicylate increased the NP 
size of Gd BDC but decreased the size of Gd BTC NPs.102 Aditionally, Melindandri’s 2016 
study investigated the impact of changing the rate of addition of the precipitating agent (NaOH) 
to the μEL/μEM microemulsion mixture. For both Cu/Zn NCPs this resulted in a reduction in 
the NP size.115 Nevertheless these studies only investigate a small fraction of available reaction 
space e.g. concentration of surfactants, type of surfactant, temperature, addition time etc.  
Given this, systematic investigation of different parameters on the NP size, morphology and 




1.4. Research Outline 
The purpose of this study is to investigate the application of microemulsion synthesis as a 
generic protocol for synthesizing morphology controlled NMOFs. Because of the large scope 
of synthetic variables in microemulsion systems, the study was limited to a w/o microemulsion 
system consisting of a variable ratio of cyclohexane, TX-100, 1-hexanol and water. As a 
generic protocol, two microemulsions were added together. These were identical, except for 
the composition of the aqueous phase. One microemulsion contains the metal salt (μEM) and 
the other contains the ligand (μEL). μEL was added to μEM at a controlled variable rate. The 
mixed microemulsion was then left stirring for a set growth time before rupturing with 
methanol and acetone and extracting by centrifugation (Figure 1.11).  
The microemulsion addition time was controlled by injecting μEL into μEM using a syringe 
pump with a set flow rate (Figure 1.12). 
The objectives of this study were to: 
1. Establish a protocol for NMOF synthesis. This was achieved by synthesizing a common 
MOF with well understood morphological behaviour (Chapter 2 - Zeolitic Imidazole 
Framework Synthesis in Microemulsions). 
2. Screen different MOFs to investigate the utility of this system for NMOF synthesis 
more broadly. 
 
Figure 1.11 Microemulsion synthesis protocol. 
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3. Investigate the influence of selected reaction variables on the morphology and topology 
of resulting MOFs crystals. The primary interest was whether the addition rate or ωo 
could be adjusted to tune the NP dimensions.  
4. Investigate the use of this technique for synthesizing protein/NMOF complexes 






Figure 1.12 (A) μEL Syringe on a syringe pump. (B)  μEL addition to μEM. (C) 
Schematic of the same process.  
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1.4.1. Characterization Techniques 
To satisfy the research goals, three characterization techniques were extensively used 
in this study. Powder X-ray diffraction (PXRD) was utilized to determine the topology of the 
synthesized material. Transmission electron microscopy (TEM) was utilized to determine the 
MOF morphology. Some experimental techniques whilst helpful were unavailable or 
unachievable during the course of this study (5.1 Experimental Challenges).    
1.4.1.1. Powder X-Ray Diffraction 
 X-ray diffraction involves shining monochromatic X-rays through a crystalline sample 
acting as a diffraction grating. A sample’s long-range ordering (topology) is determined by the 
location of bright spots on the detector (shown as dark lines in Figure 1.13), defined by Bragg’s 
law.  In powders consisting of nanocrystallites, the orientation of crystals within the sample is 
assumed to be homogenized and random. Hence, X-ray diffraction is detected from every 
periodic plane within the sample. The rotational randomization of the crystallites results in the 
formation of Debye rings on the detector, each corresponding to a periodic plane. This is plotted 
as a 1D diffroctragram, or powder pattern. The y-axis is the diffraction intensity. The x-axis is 
the scattering angle (2θ); the angle between the ring and the sample that satisfies the Bragg law 
(Figure 1.13).   
 
Figure 1.13 (Left) PXRD diffraction rings; red line represents 2θ. (Right) annotated 1D 
diffractogram. 
A material’s powder pattern can be simulated from its structure. By comparison of a 
sample’s powder pattern with known samples from a database of crystalline materials (CCDC) 
a crystalline materials structure can be identified.  






































1.4.1.2. Electron Microscopy 
Nanoparticle morphology was determined by imaging. The maximum resolution (R) of 
imaging techniques is dependent on the numerical aperture (NA) and the source wavelength 
(λ) (eq. 1.11).  
1.11  𝑹 =
𝝀
𝟐𝑵𝑨
    
Unfortunately, nanoparticles are often smaller than the maximum resolution obtained by 
optical microscopy. In electron microscopy the source wavelength is reduced to that of an 
electron beam allowing for atomic resolution. In TEM, electrons are excited from a filament, 
often tungsten, by supplying a high voltage to the filament. The electron beam is focused onto 
the sample using magnetic “lenses”. The detector detects electrons which are transmitted 
through the sample. Image contrast is obtained because fewer electrons are transmitted through 
electron dense regions of the sample due to diffraction.  
An alternative microscopy technique is scanning electron microscopy. In SEM the detector 
measures secondary electrons that are emitted from the sample surface by the electron beam. 
In SEM nonconductive samples accumulate electrons on the sample surface reducing image 
contrast (Figure 1.14). These samples must be prepared with a conductive carbon coating to 
 
Figure 1.14 TEM and SEM schematic  
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transfer electrons away from the sample surface. Unfortunately, this coating is ~10 nm thick. 
This artificially inflates the particle size and masks the particle shape. Hence TEM was used 
for sample imaging. Whilst other techniques such as cryo-TEM or HAADF STEM would 
provide higher resolution or insight into the growth mechanism, the equipment for these 
techniques was not readily available.  
1.4.1.3. Particle Size Analysis 
In accordance to best practice, the particle size distribution (PSD) obtained by TEM 
imaging is reported with the mean NP size in length, the SD and the RSD from 100 or more 
NPs. The NP size was determined automatically using imaging software (A.1.2 Transmission 
Electron Microscopy). However, this alone is insufficient to provide an accurate description of 
the PSD. This is because the PSD is not necessarily gaussian. Two samples could have the 
same SD and average size but exhibit different physical properties due to differing 
distributions.116 By modelling the PSD with a common distribution some information can be 
obtained as to the shape of the distribution. PSD data was modelled primarily with the Weibull 
curve. For modelling PSDs, the Weibull distribution was used, where x is the NP length, α is 
the shape parameter, and β is the scale parameter (eq. 1.12 & 1.13). The PDF is the probability 
distribution function or the probability that the NP length is equal to x. The CDF is the 
cumulative distribution function or the probability the NP length is less than or equal to x. This 
model was selected as it is used in PSD analysis and can model asymmetric distributions 
providing some information regarding the PSD shape unlike a gaussian distribution.117 
Throughout this work, the raw PSDs are provided in the appendixes where modelled PSDs of 
various sample are plotted together in the text as it is easie to visualize trends and ignores 
binning artefacts typical of plotting raw PSDs.  
The Kolmogrov Smirnov test (A.1.4 Kolmogorov Smirnov Tests) was used to verify that 
the fitted model matches the experimental data. This test was also used to verify that differences 























Chapter 2 -  Zeolitic Imidazole Framework Synthesis in 
Microemulsions 
2.1. Introduction 
Zeolitic imidazole frameworks (ZIFs) are a MOF subclass consisting of tetrahedrally 
arranged transition metal ions and imidazolate (IM) ligands with the overall formula ML2
*. 
They are formed due to the deprotonation of imidazole (HIM) to imidazolate (IM) ions which 
have two available metal binding sites.   
Their name is derived from their structural similarity to zeolites, a class of porous material 
consisting of interconnected XO4 (X=Al, Si) tetrads.  ZIFs possess a ~145
o bond angle across 
the M-Im-M bond; analogous to the X-O-X bond in zeolites (Figure 2.1)12. Like their zeolitic 
counterparts, ZIFs have immense structural diversity. A 2018 review by Noh and colleagues 
cites, 46 unique topologies and 239 experimentally discovered ZIF frameworks. Whilst this 
allows significant diversity in the applications of ZIFs, it makes topological control of these 
materials complex. The archetypical ZIF, ZIF-1 (Zn(IM)2) has 23 known alternate topologies 
that can be synthesized using the same precursors and typically defaults to nonporous dense 
topologies.16    
  
 
*ZIF nomenclature is loosely defined16. Structures can be named differently but still recognized as ZIFs 
providing this definition fits e.g. CDIF-4 (Cd(eIM)2)
118, 119. Furthermore, structures derived from ZIFs are 






Figure 2.1 (A) imidazole. (B) Typical X-IM-X bond angle within ZIFs. (C) Selected 
imidazolate derivatives that have been used to make ZIFs. 
A breakthrough in ZIF chemistry was achieved by Huang and colleagues in 2006. By 
substituting the hydrogen on the second carbon of the imidazolate ligands with a methyl (mIM) 
or ethyl group (eIM), denser topologies became sterically unfavourable. This resulted in the 
formation of three new MOFs: MAF-4 (Zn(mIM)2), MAF-5 (Zn(eIM)2) and MAF-
6(Zn(mIM/eIM)2). MAF-4, more commonly known as ZIF-8, possesses a sod topology with 6 
square faces and 8 hexagonal faces (Figure 2.2). The synthesis of ZIF-8 was significant as it 
was the first open framework ZIF produced and it had a reasonable BET surface area of 1030 
m2 g-1.121 More recently, improved protocols for the evacuation of ZIF-8 pores has resulted in 




Figure 2.2 ZIF-8 and sod topology viewed along the [100] and [111] planes. 
2.1.1. Synthesis and Application  
ZIF-8 is one of the most common MOFs in the literature with applications in catalysis, gas 
storage and drug delivery etc.16 It often used a model MOF for investigating new synthetic 
protocols or characterization techniques. This was highlighted in 2018 by Cleuvenbergen and 
colleagues. They demonstrated the use of a new nonlinear optical technique as a benchtop 
method to monitor the topology and morphology during in situ crystal growth. As a model for 
MOFs, this technique was tested using ZIF-8.122   
A major advantage of ZIF-8 over other MOFs is that it is easily synthesized in a wide range 
of conditions and is stable to aqueous and alkaline solvents.12 Hence, ZIF-8 has been prepared 
with protocols including flow synthesis,123 mechanosynthesis124 and microemulsion 
synthesis.69, 108, 112 Furthermore, it has a wide variety of facile room temperature synthetic 
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protocols. The first of which was demonstrated by Cravillon and colleagues in 2009.125 They 
synthesized ZIF-8 in methanol with an 8:1 ligand to metal ratio. This was expanded upon by 
Pan and colleagues in 2011. They made the first aqueous room temperature protocol by upping 
the ligand to metal ratio to 70:1.126 This has extended its application into the encapsulation of 
thermally and solvent sensitive materials and drug delivery (Chapter 3 - In situ Protein 
Encapsulation in Microemulsions). 
2.1.2. Morphology  
Throughout the literature, the morphology of ZIF-8 crystals has been extensively studied 
particularly for the purposes of producing colloidal NPs for drug delivery. As such, a wide 
range of different morphologies have been produced. The three most prevalent ZIF-8 
morphologies are: rhombic dodecahedron (RD), cubic and truncated rhombic dodecahedron 
(TRD)(Figure 2.3). In 2012, Cravillon demonstrated that these morphologies occur due to 
competitive growth along the [100] and [111] crystal facets by imaging samples at different 
growth stages. Whilst initial particles exhibit a cubic morphology due to [100] growth, 
increased growth times allowed evolution of the [111] facet. Thus, cubic crystals morph into 
truncated rhombic dodecahedrons and eventually rhombic dodecahedral crystals over time. By 
isolating the samples after different reaction times cubic and TRD morphologies could be 
obtained.127 A milestone in ZIF-8 shape control was achieved by Pan and colleagues in 2011, 
who managed to synthesize ZIF-8 using surfactant assisted synthesis with CTAB. The addition 
of CTAB slowed growth along the [100] facet allowing cubic and TRD crystals to be isolated. 
This approach has been utilized to discover a range of different ZIF-8 morphologies.91 For 
instance, tris(hydroxymethyl)aminomethane (TRIS), which slows growth along the [111] facet, 
was added to ZIF-8 during solvothermal synthesis. By changing the concentration of TRIS 
from 50 to 100 mM, the NPs changed shape from octahedral to nanoflowers. They further 
experimented on using a combination of CTAB and TRIS to produce novel burr box and 
hexapod morphologies.128  
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Figure 2.3 (A) RD and (B) TRD geometries. Photograph obtained from the HYBYCOZO 
exhibit at the TSB Festival of Lights in Taranaki New Zealand. (C) Formation of ZIF-8 
crystals by [111] directed growth. 
Except for microemulsion synthesis, ZIF-8 particle size in literature reports ranges from 9 
nm to several μm. Typically, reports of tuneable particle size originate from reaction parameter 
optimization. For instance, it is widely acknowledged that increasing the ligand to metal ratio 
reduces the particle size by increasing the nucleation rate. The most comprehensive study on 
this condition was by Kida and colleagues in 2013. They demonstrated that by changing the 
ligand to metal ratio from 40:1 to 100:1 in an aqueous solution the particle size decreased from 
2 μm to 250 nm.82 It is also acknowledged that by adding amines to the synthesis the particle 
size will decrease. This is because the addition of amines deprotonates HmIM allowing faster 
sequestration of Zn2+ by the deprotonated sites. This method was utilized by Cravillon and 
colleagues in 2011 to produce 9 nm ZIF-8 NPs by adding n-butylamine to the synthesis.129 The 
size control methods discussed thus far can be rationalized by LaMer theory, however this is 
not always the case. ZIF-8 particle size increases with increased concentration of Zn2+ and 
HmIM. This is counterintuitive according to LaMer theory. This result was justified by Yeung 
and colleagues using a model whereby ZIF-8 growth is dictated by two processes (Figure 2.4). 
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Firstly, Zn2+ coordinates to mIM/HmIM nitrogen atoms. Secondly, HmIM is deprotonated to 
mIM creating an additional binding site. It should be noted that the solvent competes with 
mIM/HmIM for Zn2+ binding sites to alter the nucleation rate. Increased concentration results 
in faster sequestration of HmIM by Zn2+. This slows later growth because the resulting product 
is Zn(HmIM)4
2+ which has no available binding sites. Slower initial growth produces molecules 
such as Zn(mIM)2 which has two available mIM and zinc binding sites.
77 This model can also 
be used to explain prior results. For instance, whilst the increased ratio of HmIM to Zn2+ 
increases the initial nucleation rate, it also increases the availability of mIM because HmIM is 
basic and can deprotonate other HmIM molecules.    
 
Figure 2.4 ZIF-8 growth schematic. x is equal to 1,2 or 3.  
2.1.3. Microemulsion Synthesis 
Given the extensive literature available on the morphology of ZIF-8, the availability of 
aqueous synthetic protocols for comparison, and its common use as a testbed MOF, ZIF-8 is 
an ideal candidate for investigating microemulsion synthesis. Unsurprisingly, three studies 
have already been conducted on the use of microemulsion synthesis to synthesize ZIF-8. The 
Sun group synthesized ZIF-8 in a water/TX-100/hexanol/ionic liquid microemulsion and a 
water/CTAB/hexanol/cyclohexane microemulsion.108, 112 In both cases, they produced 2.2-2.3 
nm spherical NPs; the smallest samples on record. Chulkaivalshucharit reported the synthesis 
of 30 nm RD ZIF-8 crystals containing the protein horseradish peroxidase.69 However, between 
all three studies the only parameter investigated was the concentration of Zn2+ and mIM. No 
correlation was found with the NP size. Thus, significant work is still required to investigate 
the impact of synthetic parameters on ZIF-8 morphology  
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2.1.4. Research Outline 
In this chapter, a TX-100 based w/o microemulsion was used to synthesize ZIF-8, its cobalt 
analogue, ZIF-67, and ZIF-1 (Zn(IM)2). The objectives of this chapter were as follows: 
1. Establish a microemulsion method to synthesize MOF NPs using ZIF-8 as an 
exemplar. 
2. Evaluate the effect of changing various conditions on the overall morphology of the 
ZIF-8 product. 
3. Screen different ZIFs to investigate the use of this technique as a generic 
morphology control method.  
The ligand and metal combinations selected for screening were Co2+/HmIM and Zn2+/HIM. 
The combination of Co2+ and HmIM usually forms ZIF-67, Co(mIM)2, the sod cobalt analogue 
of ZIF-8. It displays very similar morphological behaviour and is often synthesized by simple 
substitution of the precursor zinc(II) salt by its cobalt(II) analogue. Furthermore, ZIF-67 is a 
highly regarded catalytic MOF. In addition to being used as a template for the synthesis of 
other catalytic materials, ZIF-67 is used in applications such as photocatalysis and 
electrocatalysis. This was highlighted by Qin and colleagues who demonstrated that ZIF-67 
could be utilized as co-catalyst for the photoreduction of CO2 to CO. In addition, ZIF-67 
demonstrated an improved performance over other commonly utilized MOFs including ZIF-8, 
MIL-100-NH2 and UiO-66-NH2. A quantity of just 0.1 mg of ZIF-67 produced 29.6 μmols of 
CO over a 30 minute period compared to the next highest value of 4.7 μmols (MIL-100-
NH2)
130. 
As mentioned earlier, the combination of Zn2+ and HIM can produce multiple different 
topologies. The simplest ZIF, ZIF-1, is Zn(IM)2 and it adopts the crb topology. However, ZIF-
1 is of little research interest due to its low porosity.12 However, the cag topology of ZIF-4, 
which also has the Zn(IM)2 formula, is often studied. This is often because it can be melted to 
form a porous glass at 300 oC.131 MOF glasses are highly valued for producing membranes for 
gas filtration. Typically, MOF membranes are made by mixing a polymer and MOF together. 
These membranes can have gaps and defects at the boundary between the two materials: 
compromising their gas selectivity. These are not apparent with MOF glasses.132 
Morphological tuning of ZIF-4 would be valuable as it would potentially allow further study 




2.2.Results & Discussion 
The initial microemulsion ZIF-8 synthesis methodology was provided by Otago University 
through correspondence (ZIF-8a-1x)(2.4.2 Microemulsion ZIF-8 Synthesis).The PXRD of this 
ZIF-8a material possesses peaks at 7.3o, 10.3o, 12.7o, 14.6o, 16.4o, 17.9o (Figure 2.5A). These 
are characteristic of the [011], [002], [112], [022], [013], and [222] lattice planes. This is 
consistent with the sod topology of ZIF-8. However, this synthetic method had several issues. 
Primarily, it produced a low absolute yield of ~1 mg which made it difficult to perform multiple 
characterization analyses on the same sample batch. Additionally, whilst most crystals had a 
RD morphology this was far from consistent (Figure 2.5C-D & B.1). Furthermore, the particle 
size achieved was 68.7 ± 31.3 nm (N = 101) (Figure 2.4B). Whilst this in the desired 
nanoparticle size range, the SD is 45.5 % of the mean; hence, the sample has a broad PSD. This 
PSD could not be modelled with a continuous distribution (Figure B.2) possibly indicating 
polydispersity within the sample.  
The strategy adopted to improve the yield was to increase the amount of TX-100, hexanol, 
and the aqueous phase increased four-fold by mass (ZIF-8d-120). This significantly increased 
the yield to 41.5 mg; an increase that could not solely be attributed to the increased 
concentration of reactants. This was likely the result of extraction from the solution being 
considerably easier with a more concentrated solution. By making this change the morphology 
also became much more uniformly rhombic dodecahedral (though some cubic particles can 
still be seen by TEM). The NP size increased to 87.3 ± 22.4 nm (N = 131). Whilst, the overall 
size increased, the percentage SD decreased to 25.6%. This is generally considered 
monodisperse. Because of the increased yield and improved dispersity, this sample was used 







Figure 2.5 (A) PXRD patterns and (B) plot of the particle size distributions (PSD). TEM 
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2.2.1. Addition Rate 
Samples were then synthesized using a variable addition time. The ligand microemulsion 
(μEL) was added to the metal microemulsion (μEM) dropwise using a syringe pump over a 0, 
15, 30, 60, 90 and a 120 min period. For the 0 min synthesis, μEL was directly pipetted into 
μEM. Samples were denoted ZIF-8b-time except the 30 min and 120 min samples which were 
denoted ZIF-8d-2 and ZIF-8d-1 respectively. Samples denoted ZIF-8d appear in multiple 
subsections of this chapter. The PXRD profile of all samples is consistent with ZIF-8 (Figure 
2.6A). No additional peaks were identified indicating that topologically pure sod ZIF-8 was 
formed.  
The sample morphology varied with the addition time (Figure 2.6C-H). When μEL was 
added directly to μEM, the crystals exhibited a uniformly pseudospherical morphology. This 
was consistent with the 15 min synthesis. It is unclear as to why spherical crystals would form 
in these conditions. It is possible that the small size of the crystals limited visibility of the 
crystal edges and factes giving them the appearance of spherical particles. As the addition time 
increased to 30 min RD particles became predominant. Whilst this remained the case for longer 
addition times, cubic and TRD crystals were also noticeable in the 90 and 120 min samples. 
Shorter addition times generally result in a faster initial nucleation rate and more time spent in 
the crystal growth phase. This is consistent with the observed morphologies as the samples 
with shorter addition times did not display cubic and TRD particles which are generally 
apparent in early stages of crystal growth.  
As the addition rate decreased the particle size increased (Figure 2.6B, B.3 & Table B.2). 
However, the increase in particle size became less apparent at longer addition times. For 
example, the average size of ZIF-8b-0 was 27.3 ± 9.1 nm (N = 103). ZIF-8b-30 was an average 
of 74.6 ± 18.0 nm (N = 107). Hence, a change of 30 min resulted in a 50.9 nm change in NP 
size. ZIF-8b-90 had a particle size of 78.2 ± 25.7 nm (N = 118). Hence, the same 30 min change 
in addition time induced only a 9.1 nm change in NP size. This increased to 87.3 ± 22.4 nm (N 
= 131). As a general trend, the SD in particle size tended to increase with addition time. 
However, the RSD remained relatively consistent between 33.4% and 24.1%. Interestingly, 
sample ZIF-8b-0 possessed the lowest SD and the highest RSD (9.1 nm, 33.4%). The small NP 
size of this sample causes small SD values to result in relatively large RSD values.  
Given the success of size tuning ZIF-8 nanoparticles using the addition rate, future work 
could focus on the physical properties of these samples e.g. gas adsorption and 
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thermogravimetric analysis should be used to investigate whether the NP size influences the 
surface area or decomposition temperature of these samples.   
 
 
Figure 2.6 (A) PXRD patterns and (B) Weibull modelled PSD displaying the (Outset) PDF 
and (Inset) CDF for ZIF-8 samples synthesized with a variable addition time. Individual data 
points show the empirical CDF (ECDF). TEM images of ZIF-8 synthesized with a (C) 0, (D) 
15, (E) 30, (F) 60, (G) 90 and (H) 120 min addition time. The scale bar is 200 nm.   
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It should be noted that the PSD of almost every sample in this chapter was adequately 
described with both the Weibull and Gaussian distributions. However, this was not the case for 
ZIF-8b-0; the smallest sample ZIF-8 in this chapter. ZIF-8b-0 was adequately described with 
a Weibull but not Gaussian distribution. Comparison of the CDF and PDF of both models 
shows (Figure 2.7& Table B.1) a broader Weibull distribution. However, a rapid drop-off 
occurs in the lower tail of the Weibull distribution suggesting an asymmetric distribution. With 
the Gaussian model 9% of NPs are less than 10 nm in size. This reduces to 4% for NPs less 
than 5 nm in diameter. For the Weibull distribution, the equivalent values are 3% and 0.3%. 
This is consistent with the raw data, where the smallest observed NP was 11.9 nm. The average 
length and standard deviation corrected for the Weibull model is 27.2 ± 9.7 (N = 103) RSD 
35.7 %.  Lower tail asymmetry also occurs for the two smallest samples from 2.2.2 ωo. In 
classical nucleation theory, NPs are considered metastable below a critical radius because of 
their tendency to aggregate or dissolve. This could explain why sub-10 nm NPs are not present 
in the sample despite a uniform distribution predicting that they would be.  
 
Figure 2.7 (A) PDF and (B) CDF of ZIF-8b-0 PSD  
In comparison to the literature ZIF-8b-0 is one of the smallest samples on record. Four 
studies have managed to produce smaller NPs.108, 112, 129, 133 Whilst Cravillon and colleagues 
managed to produce several samples smaller than ZIF-8b-0, measurements were performed 
using SAXS and in situ PXRD and no PSD information was provided.129 In 2018, Lan and 
colleagues synthesized 27 nm ZIF-8 by adjusting the ligand metal ratio to 55:1. In their case, 
the NP size was obtained through TEM and the experimental PSD was provided. However, 
this came in the form of a histogram without the raw data. The dispersity was not calculated; 
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hence it is difficult to compare the PSD of this sample with ZIF-8b-0. However, from the 
experimental PSD no NPs less than 15 nm were present.133  
However, the idea that ultra-small ZIF-8 NPs are unstable is contradicted by the two 
microemulsion studies by Sun’s group, which reportedly synthesized ~2 nm NPs.39, 108 
However, this is not the only unusual feature of these studies. Firstly, PXRD can be used to 
determine the crystallite size using the Debye-Scherrer equation. (Side-note: This was not 
performed in this chapter because the technique is only accurate for small NPs and our PXRD 
instrument has significant instrumental broadening. This would have created inaccuracies in 
the larger ZIF-8 samples). In the case of the putative 2.2 nm ZIF-8 NPs, significant broadening 
of the PXRD peaks would have been expected because of the reduction in the number of 
periodic units along each plane (Figure B.4). This broadening was not observed in Sun’s 
studies. Secondly, CTAB and TX-100 w/o microemulsions behave very differently. The same 
NP synthesized using both systems can have drastically different sizes and morphologies.134 
Hence, it is unusual that these systems would have produced ZIF-8 NPs with remarkably 
similar morphologies, as reported. Thirdly, sub-10 nm MOF NPs are incredibly rare. Whilst, 
Cravillon demonstrated that this was possible for ZIF-8, the number of repeating units in a 
(connectivity) 9 nm and 2.2 nm ZIF-8 NPs are incomparable. In one case, the average NP 
contains 78 unit cells, whereas the other would possess just over 1 unit cell (unit cell length = 
1.7012 nm).129 Two cases of MOF NPs with comparable dimensions are noted: HKUST-1 (2.6 
nm)135 and UiO-66 (~4 nm)(Chapter 4 - Microemulsion Synthesis of UiO-66). In both cases, 
significant PXRD peak broadening was observed. Furthermore, both MOFs have greater 
connectivity than ZIF-8; this would improve the stability of ultra-small NPs. HKUST-1 has 4 
BTC molecules per copper paddle-wheel cluster and three paddlewheels per BTC ligand. UiO-
66 has 12 BDC molecules per zirconium cluster and two clusters per BDC molecule. Given 





ZIF-8 was synthesized with ωo values of 22.3, 16.7, 11.1, 10 and 5.6. These correspond to 
4.0, 3.0, 2.0, 1.8, and 1.0 mL of the aqueous phase used during synthesis. The samples were 
denoted ZIF-8c-volume e.g. ZIF-8c-4. The 1.8 mL sample was ZIF-8d-30. All samples 
displayed PXRD peaks expected for ZIF-8 and appeared to be phase pure (Figure 2.8A). 
When imaged by TEM (Figure 2.8C-E), all samples displayed mostly rhombic 
dodecahedral crystals. On closer inspection, ZIF-8c-4 possesses a significant portion of 
irregularly shaped NPs. Interestingly, there appeared to be no apparent correlation between NP 
size and the water volume (Figure 2.8B, B.5 & Table B.3), despite significant variability in NP 
size between samples. At the upper end of sizes, the 1.8 mL sample produced a NP length of 
74.7 ± 24.0 (N = 107). At the lower end, the 3 mL sample led to a NP length of 39.9 ± 15.9 (N 
= 218). Furthermore, significant range exists in the samples’ dispersity with RSD values 
ranging from 24.0% for the 1.8 mL sample to 39.3% for the 3 mL sample. The lack of 
correlation between ω0 and the NP size is in contradiction with a templating model of 
microemulsion synthesis. The templating model would suggest the NP size would decrease as 
the amount of water (and ω0) decreased. Interestingly, this same trend was investigated for 
UiO-66 (Chapter 4 - Microemulsion Synthesis of UiO-66) and a strong correlation was found 
between the ω0 and the NP size. This suggest that the effect of this parameter is likely due to 








Figure 2.8 (A) PXRD and (B) Weibull modelled PSD displaying the (Outset) PDF and  
(Inset) CDF. Individual data points show the ECDF. TEM images of ZIF-8 synthesized with 
(C) 4, (D) 3, (E) 2, (F) 1.8 and (G) 1 mL of aqueous phase. The scale bar is 200 nm.   
Like ZIF-8b-0, two samples could not be adequately described with a Gaussian model: 
ZIF-8c-3 and ZIF-8c-4 (Figure 2.9). The Weibull modelled NP size for these two samples 
results in NP dimensions of 39.9 ± 16.1 (N = 218, RSD 40.3%) and 60.1 ± 22.0 (N = 168, RSD 
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36.6 %). Both samples show significantly less NPs at the lower tail end of the distribution than 
would be expected by a Gaussian distribution.  
 
Figure 2.9 (A) PDF and (B) CDF of ZIF-8c-4 and ZIF-8c-3 PSD 
2.2.3. Metal Ligand Ratio 
ZIF-8 was then synthesized using a variable mIM to Zn2+ ratio while maintain a 30 min 
addition time. The Zn2+ concentration was maintained at 0.19 M. The ratios used were 40:1, 
20:1, 10:1, 5:1 and 8.42:1 (denoted ZIF-8e-equivalents e.g. ZIF-8e-40). The 8.42:1 sample was 
ZIF-8d-30. The only sample that delivered a phase pure product was the 8.42:1 ratio (Figure 
2.10A). As the ratio increases to 10, 20 and 40 additional peaks appear at 8.6 and 9.6o. 
Reduction of the ligand metal ratio to 5:1 results in additional peaks at 9.6 and 11.1o alongside 
standard ZIF-8 peaks. This is unusual behaviour since conventional aqueous synthetic 
protocols typically utilize ligand metal ratios of 40:1 or greater unless an amine is added. The 
contrasting behaviours of microemulsion and aqueous synthesis supports the notion that further 
processes are in play during microemulsion synthesis rather than simple templation of aqueous 
synthesis. Either, the template is interacting with ZIF-8 during growth or the growth kinetics 
are substantially altered by confinement within the microemulsion. To contrast microemulsion 
synthesis with aqueous synthesis, ZIF-8 was synthesized in an aqueous solution using a ligand 
equivalence of 8.42 and 40. An equivalence of 8.42 produced ZIF-L (Figure 2.10B); a topology 
of 2D sheets often formed as an intermediate in the synthesis of ZIF-8. The presence of peaks 
at 7.3, 7.8, 8.9, 10.3, 10.9 and 11.6o corresponded to the [400], [222], [004], [040], [224] and 
[404] planes of ZIF-L. This result is consistent with the prior literature.82, 136 An equivalence 
of 40 produced a typical ZIF-8 powder pattern. 
ZIF-8c-3  o raw data           Weibull         Gaussian     
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Figure 2.10 (A) PXRD of bulk and microemulsion ZIF-8 synthesized with variable ligand 
equivalents. (B) ZIF-L structure 
2.2.4. ZIF Screening 
ZIF-67 and ZIF-1 were synthesized using the microemulsion method. ZIF-67 is the cobalt 
analogue of ZIF-8 with the same sod topology. Because of its structural and chemical 
similarity, it was a useful reference point to investigate other materials. ZIF-67 was synthesized 
by substituting zinc nitrate with cobalt nitrate during standard ZIF-8 synthesis all other reaction 
conditions used for ZIF-8-d-30 were maintained. Hence, the ligand equivalence was 8.42, the 
addition time was 30 min and 1.8 mL of aqueous phase was used during synthesis. 
Unsurprisingly, the PXRD of the ZIF-67 sample was consistent with the simulated sod ZIF-67 
structure (Figure 2.11A). However, due to the structural similarity of ZIF-8 and ZIF-67 this is 
indistinguishable from ZIF-8. ZIF-67 NPs were 120.7 ± 22.0 nm (N = 105) in length. This is 
considerably larger than their ZIF-8 equivalent which was 74.6 ± 18.0 nm (N = 107) (Figure 
2.11B). This is consistent with the literature where equivalent methods generally produce larger 
ZIF-67 particles.137 In addition, the morphology of ZIF-67 is RD but considerably less well 
defined than the equivalent ZIF-8 NPs. This is likely due to the higher lability of Zn mIM bonds 
compared to the cobalt equivalent. Interestingly, except for Sun’s group which synthesized 2.3 
nm ZIF-67 NPs, the next smallest sample is 80 nm synthesized by Wang and colleagues in 
2018.138 The disparity between the size of ZIF-8 and ZIF-67 samples in the literature could be 
due to the considerably smaller subset of the literature dedicated to ZIF-67 or imply that 
synthesis of ZIF-67 NPs is considerably more difficult.  
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Figure 2.11 (A) PXRD and (B) Weibull modelled PSD displaying the (Outset) PDF and  
(Inset) CDF. Individual data points show ECDF. TEM images of ZIF-8 (C) and ZIF-67 
synthesized using the microemulsion method   
Microemulsion synthesis was used to synthesize MOFs from the combination of Zn2+ and 
HIM. These samples were denoted Zn-IM-1 and Zn-IM-2 and varied in the ω0 value (16.7, 
10.0). Interestingly, by varying the ω0 value the MOF topology and morphology varied 
substantially. Zn-IM-1 possessed PXRD peaks (Figure 2.12A) at 11.3, 11.9, 14.9 and 20.0o. 
These corresponded to the [111], [220], [131] and [151 planes of the Zn(IM)2 neb phase (Figure 
2.12B). ZIFs with the neb phase are relatively rare and has only been synthesized using 
solvothermal synthesis at 140 oC in two studies.139, 140 Hence, a new ambient protocol for the 
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synthesis of Zn(IM)2 neb is at least interesting. Unfortunately, Zn(IM)2 neb is not a particularly 
desirable product as it has low stability and porosity. However, the low porosity of this material 
is generally the result of adding a templating agent which occupies the MOF pores e.g 
pyridine.139 This is a procedure that is not performed during microemulsion synthesis. Hence, 
determining the porosity of this material using gas adsorption would be worthwhile for future 
study. As to Zn-IM-2, despite comparison to all known Zn2+/IM topologies, this material could 
not be identified. To identify this material, Rietveld refinement of the crystal structure from 
PXRD data is required. However, it would be preferable if this were performed on synchrotron 
data to reduce background noise and instrumental broadening in the PXRD. As to the 
morphology (Figure 2.12C & D), Zn-IM-1 tended to form large aggregates. Surprisingly, Zn-
IM-2 formed relatively uniform pseudospherical NPs ~ 70 nm in length.  
It is interesting to note that the topology of ZIF materials was altered by adjusting the ω0 
value. This is the first instance of topological changes being observed due to the adjustment of 
microemulsion parameters. Given this, it would be interesting to do a comprehensive 
investigation on different microemulsion parameters and their resulting Zn-IM topology. 







Figure 2.12 (A) PXRD of Zn-IM samples. (B) Zn(IM)2 neb structure. TEM images of (C) 
Zn-IM-1 and (D) Zn-IM-2.   
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In conclusion ZIF-8 was successfully synthesized with nanoscale dimension using the TX-
100/hexanol w/o microemulsion system. Interestingly, no correlation could be observed 
between ωo and the NP size. Furthermore, microemulsion synthesized ZIF-8 lost phase purity 
when synthesized with greater ligand/metal ratios. Both behaviours would not be expected if 
templation of an aquous synthesis was the primary mechanism for MOF growth in this system. 
This suggests templated aqueous growth is not the primary mechanism for size control. This is 
further supported by the success of synthesis with an 8.42 ligand equivalence which is atypical 
of standard aqueous synthesis. Despite this nonstandard behaviour NP size control was 
achieved through changing the addition time. NP length was adjusted from 27.3 ± 9.1 to 87.3 
± 22.4 by changing the addition time from 0 to 120 min. Microemulsion synthesis was then 
applied to synthesize ZIF-67 and Zn(IM)2 neb. When measuring the NP size and distribution, 
the reporting standard adopted by Marshall and colleagues was used. However, this does not 
account for changes in the PSD. Three ZIF-8 samples were synthesized which did not conform 
to a standard Gaussian distribution. It is recommended that future studies provide the ECDF to 
allow comparison of the PSD shape.  
2.4. Experimental Methods 
2.4.1. Materials  
All chemicals and reagents were sourced from commercial suppliers at a purity of 99.8% 
or greater and used without further purification. 
2.4.2. Microemulsion ZIF-8 Synthesis 
For all ZIF-8 samples prepared using microemulsion synthesis, two solutions were 
prepared by mixing various quantities of TX-100, 1-hexanol and cyclohexane. To each mixture 
an aqueous solution containing either Zn(NO3)2.4H2O (0.19 M) or HmIM was added. The 
volume of aqueous phase in μEM and μEL was always the same.  Both microemulsions were 
left stirring for 24 hours to homogenize. μEL (20 mL) was added to μEM (20 mL) dropwise 
over a set addition time. The solution was then left stirring for an hour. The resulting mixture 
was ruptured with methanol/acetone (50% v/v, 20 mL). MOF crystals were extracted by 
centrifugation at 6000 rpm for 20 min. The extracted solid was washed with acetone, 
cyclohexane, and methanol (10 mL) before lyophilization overnight. The composition and 













min mL mmol g mmol mL mmol ml M M 
ZIF-8a-1x 120 20 185 1.56 2.41 0.6 4.82 0.45 0.19 1.6 8.42 
ZIF-8b-0 0 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8b-15 15 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8b-60 60 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8b-90 90 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8c-4 30 20 185 6.24 9.64 2.4 19.3 4 0.19 1.6 8.42 
ZIF-8c-3 30 20 185 6.24 9.64 2.4 19.3 3 0.19 1.6 8.42 
ZIF-8c-2 30 20 185 6.24 9.64 2.4 19.3 2 0.19 1.6 8.42 
ZIF-8c-1 30 20 185 6.24 9.64 2.4 19.3 1 0.19 1.6 8.42 
ZIF-8d-120 120 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8d-30 30 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.6 8.42 
ZIF-8e-40 30 20 185 6.24 9.64 2.4 19.3 1.8 0.19 7.6 40 
ZIF-8e-20 30 20 185 6.24 9.64 2.4 19.3 1.8 0.19 3.8 20 
ZIF-8e-10 30 20 185 6.24 9.64 2.4 19.3 1.8 0.19 1.9 10 
ZIF-8e-5 30 20 185 6.24 9.64 2.4 19.3 1.8 0.19 0.95 5 
 
2.4.3. Microemulsion ZIF-67 & Zn-IM synthesis 
ZIF-67 was synthesized in a microemulsion using the procedure outlined in 2.4.2 
Microemulsion ZIF-8 Synthesis for sample ZIF-8d-30. Zn(NO3)2.4H2O was substituted the 
same concentration of Co(NO3)2.4H2O (0.19 M).  
Zn-IM-1 & Zn-IM-2 samples were prepared using the procedure outlined in 2.4.2 
Microemulsion ZIF-8 Synthesis for sample ZIF-8d-30. The aqueous phase of μEL was 
substituted with an aqueous HIM solution (1.9 M). μEL & μEM were prepared with a variable 
aqueous phase volume (Zn-IM-1, Zn-IM-2: 3 mL, 1.8 mL). 
 
* Composition of constituent microemulsions used to make the sample. E.g. sample ZIF-8a-1x is made from two 
microemulsions both are composed of 20 mL cyclohexane, 1.56 g TX-100, 0.6 mL hexanol and 0.45 mL aqueous phase. The 
aqueous phase is either 0.19 M Zn2+ or 1.6 M HmIM. 




2.4.4. Aqueous ZIF-8 Synthesis 
ZIF-8 was synthesized by mixing aqueous Zn(NO3)2.4H2O (0.19 M, 20 mL) with 20 mL 
of an aqueous HmIM solution of variable concentration (1.6 M, 7.6 M). The sample was left at 
room temperature without stirring for 24 hours. Crystals were extracted from the solution by 
centrifugation at 6,000 rpm for 20 min. The sample was washed 3x with water (10 mL) before 
lyophilization.  
2.4.5. Transmission Electron Microscopy 
Samples were prepared for TEM imaging by dispersing ~1 mg in 1 mL ethanol and 
sonicating for 20 seconds. A drop of this solution was added to a negative staining grid and left 
for 5 minutes before drying and imaging using a FEI Tecnai G2 Biotwin transmission electron 
microscope. NP size information was determined using ImageJ 1.52a. Threshold masking was 
determined manually, and the particle size was determined with holes excluded. The Feret’s 
diameter was used as the NP length (A.1.2 Transmission Electron Microscopy). NP size was 
determined across ~100 samples.   
2.4.6. Powder X-Ray Diffraction  
X-ray diffraction data was collected using a Rigaku Spider diffractometer equipped with a 
Micromax MM007 rotating anode generator with Cuα radiation (λ = 1.54180 Å), high flux 
osmic multilayer mirror optics, and a curved image plate detector, and finally processed into 







Chapter 3 -  In situ Protein Encapsulation in Microemulsions 
3.1. Introduction 
A recent application of MOFs is to use them as substrates for the immobilization of proteins 
and protein catalysts (enzymes). Proteins are highly sought after as industrial catalysts, 
biosensors, and drugs due to their high selectivity, reactivity and perceived environmental 
friendliness.141 However, their applicability is often limited by their low-stability and 
recyclability. Protein recyclability can be improved by immobilization onto solid substrates 
such as hydrogels142-144, carbon nanomaterials145, zeolites and MOFs. Such composites can 
often be more readily extracted from reaction media then reused. Furthermore, protein stability 
can be enhanced if immobilized internally within the pores of a substrate. This process is known 
as encapsulation.146 In this thesis protein encapsulating MOF complexes are denoted 
protein@MOF.  
Protein stability is enhanced by encapsulation by preventing denaturation, which can 
otherwise occur through unfolding/agglomeration due to slight changes in the local 
environment.147, 148 For instance, high temperatures,147, 149, 150 chemical agents,151 and 
proteases149 have all been observed to cause denaturation. By encapsulating a protein within a 
MOF the protein is stabilized by two mechanisms. The first is that it prevents access to the 
protein by denaturing agent. For instance, horseradish peroxidase (HRP)@ZIF-8 is protected 
from trypsin (a common protease) induced denaturation because trypsin is too large to enter 
the MOF pores.149 The second mechanism is that confinement within the MOF reduces the 
structural mobility of the protein to prevent unfolding. For instance, Liao and colleagues made 
catalyse@ZIF-90 and introduced urea at 80 oC. Free catalyse showed no activity when exposed 
to urea, whereas the activity of catalyse@ZIF-90 was preserved. They then encapsulated urease 
in ZIF-90. Urease degrades urea and increases the solution pH. Urease maintained its activity 
despite internal its encapsulation in ZIF-90, implying that urea can be accommodated in the 
MOF pores.151  
3.1.1. Enzyme Encapsulation in MOFs 
MOFs are particularly sought out encapsulation substrates. Their enormous internal surface 
area provides a significant area for intermolecular interactions with the protein surface. Hence, 
MOFs typically have a high loading efficiency* (LE) and low leaching rate compared to other 
encapsulating substrates.152 In addition, by modifying the ligands MOFs have been designed 
to further enhance LE through protein-MOF interactions such as π-π stacking or covalent 
 
* Mass of encapsulated protein as a percentage of the total protein-substrate complex mass.  
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linkages.153 Furthermore, because of their extensive structural diversity, MOFs can be 
functionalized to have roles beyond simply being a protein carrier. For instance, by selecting 
the pore dimensions MOFs can allow specific substrates selective access to enzymatic active 
sites; enhancing catalytic specificity. This was highlighted by Knedel and colleagues by 
encapsulating laccase within ZIF-8. The resulting laccase@ZIF-8  could catalyse the substrate 
2,6-dimethoxyphenol but not the bulkier dye 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic 
acid (ABTS). This indicates ABTS could not enter the ZIF-8 pores to reach the laccase active 
sites.154 Another example of the functional role of MOFs in protein@MOF complexes was 
demonstrated by Li and colleagues. They synthesized cytochrome C@HKUST-1. Cytochrome 
C catalyses the decomposition of hydrogen peroxide. They postulated encapsulation in 
HKUST-1, a Cu2+ containing MOF, would result in a protein@MOF complex with greater 
activity than the protein. This was because Cu2+ promotes increased cytochrome C activity and 
HKUST-1 also catalyses the degradation of hydrogen peroxide. This postulation proved true 
and a 12-fold increase in catalytic activity was observed in cytochrome C@HKUST-1 
compared to cytochrome C.155 
To date, there are four categories of techniques to immobilise proteins to MOFs: surface 
adsorption, covalent attachment, post synthetic loading and in situ synthesis.146 The first two 
are solely immobilization techniques and will not be covered. However, they have been 





Figure 3.1 Protein encapsulation within (A)  NU-1000 using post synthetic loading and (B) 
ZIF-8 using in situ synthesis. 
3.1.1.1.Post Synthetic Loading 
Post synthetic loading, was pioneered by Lykourinou  and colleagues in 2011 to 
encapsulate the protein MP-11 in TB-mesoMOF.152 The technique involves pre-synthesizing 
the MOF and then loading the enzyme into the MOF pores. The protein is stabilized within the 
pores by intermolecular interactions with the MOF surface.153 Two design rules have been 
proposed to optimize the catalytic efficiency of these materials. The first states the MOF should 
contain pores of similar dimensions to the encapsulated protein. If the protein is significantly 
larger than the pore dimensions, it will not be incorporated into the pore*. If the other way 
around, the MOF-protein surface interactions will be reduced, and the protein will not be 
retained in the MOF. The second design rule states the MOF should be hierarchically porous 
i.e. it should have multiple pores of different dimensions. One set of cavities can be utilized to 
encapsulate proteins while the other can be kept free. Free pores act as channels for reactants 
to diffuse to protein active sites increasing catalytic rates within the crystal.159 These two design 
rules were utilized by Lian and colleagues to encapsulate glucose oxidase (GOx) and HRP 
within PCN-888. PCN-888 has 3 pores of different diameters (6.2, 5.0 and 2.0 nm). The 6.2 
 
* Proteins can be encapsulated within MOFs where the pore aperature is smaller than the protein. This is achieved 
by a conformational shift in the protein to squeeze into the MOF pores.158 
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pore was used to encapsulate HRP. GOx was encapsulated in the 5.0 nm pore and the third 
pore was left free. The resulting GO/HRP@PCN-888 was used to catalyse the conversion of 
the ABTS dye to its blue form (Figure 3.2). This was attributed to the paired location of HRP 
and GOx. This allowed fast transport of hydrogen peroxide from GOx to HRP.160  
 
Figure 3.2 GOx/HRP catalysed tandem reaction 
Whilst pore/protein size pairing allows for precise control over loading and catalytic 
properties, it severely limits the enzyme/MOF combinations that can be made. The requirement 
for size pairing limits the applicable MOFs to those with several nm pores e.g. NU-1000 (3.1 
nm pore).161 In theory, pore expansion could be achieved by isoreticular synthesis using larger 
ligands e.g. NU-1007 (6.7 nm pore). However, the synthesis of the required ligands becomes 
both tedious and difficult limiting the practicality of this approach.162, 163 
3.1.1.2. In Situ Synthesis  
In situ synthesis refer to methods where the protein is encapsulated within the MOF as part 
of the MOF synthesis procedure. In these approaches, the MOF forms around the protein 
creating a large cavity or defect where the protein resides. The earliest in situ procedure, 
coprecipitation, involves adding a capping agent to the protein before introducing the MOF 
precursors.164, 165 This was pioneered by Lyu and colleagues in 2014, to encapsulate polyvinyl 
propylene (PVP) capped cytochrome C within ZIF-8 via room temperature synthesis in 
methanol.164  An alternative approach, known as biomineralization, was later developed by the 
Doonan group in 2015.149 In this approach, the protein surface acts as a nucleation site to 
sequester charged precursor ions to induce MOF nucleation.166 Whereas Lyu and colleagues 
used PVP to stabilize the protein from denaturation within methanol, Doonan’s group 
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conducted the synthesis in an aqueous environment where the addition of the coprecipitating 
agent was unnecessary. 149, 164, 165  
Like post synthetic loading, only a limited range of MOFs can be used for in situ synthesis. 
This is because the MOF must be synthesized in ambient conditions where the protein will not 
denature. As such, ZIFs have been commonly used for this approach; particularly ZIF-8.146 
Other MOFs such as HKUST-1155, 167 and UiO-66-NH2
124 have also been used to some extent. 
However, this approach provides significantly more diversity in the range of biological 
materials that can be encapsulated as there is no limitation on their size. This was dramatically 
highlighted by Doonan’s group who coated an entire yeast cell (~4 μm) with ZIF-8 (1.16 nm 
pores).168 Due to the flexibility and relative ease of in situ methods, their use has expanded to 
other biological materials such as RNA complexes169 and viruses.170 
One of the defining advantages of in situ encapsulation is the improvement of 
protein@MOF stability. Because the encapsulated material is often larger than the pores of the 
surrounding MOF, the biological material is entrapped and prevented from leaching out of the 
MOF.146, 149, 171 However, this is not always the case. Gascon and colleagues observed between 
~5 and 10% protein leaching within a 30-hour period for in situ synthesized β-
glucosidase@NH2-MIL-53. However, this composite is unusual in the in situ literature because 
it could be produced using both in situ and post synthetic means.150 Therefore, β-glucosidase 
is small enough to enter and exit the MOF pores. Hence, β-glucosidase is not confined within 
NH2-MIL-53 in the same manner that is typical for in situ protein@MOF complexes. Despite 
this, the 5 to 10% observed leaching of in situ synthesized β-glucosidase@NH2-MIL-53 is still 
reasonably low. The comparative post synthetic complex displayed ~20% protein leaching over 
the same time period.150 Why this is the case is not entirely known.150     
Furthermore, since the MOF is grown around the protein, the formed cavity size is 
comparable to the encapsulated protein. Thus, the protein’s mobility and denaturation is highly 
restricted. For this reason in situ complexes often have high stability to denaturing conditions. 
For instance, HRP@ZIF-8 could retain 88% of its activity despite boiling in DMF at 153oC.149  
3.1.1.2.1. Crystal Growth and Design 
The major drawback of in situ synthesis is the lack of synthetic control. The target when 
synthesizing protein@MOF complexes is often to maximise their catalytic activity. This is 
predominantly a product of the LE and the retained protein catalytic activity upon 
encapsulation. Unfortunately, these properties are very sensitive to the reaction environment 
e.g. concentration of precursors,69, 172 or presence of salts.173 Substituting the MOF or protein 
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can lead to dramatic variations. For instance, MAF-7 encapsulates catalase with an LE of 0.9%, 
whereas the LE of catalase@ZIF-8 is 3.3%.174 Furthermore, when encapsulated in FeBTC, 
alcohol dehydrogenase retains just 3.7% of its activity. GOx@FeBTC synthesized using 
approximately the same amount of protein had an activity of ~240% of its native state.172 
However, the effectiveness of these materials is not solely a contribution of their reaction 
environment or MOF protein selection. The spacial arrangement of proteins within the MOF 
can dramatically influence their overall properties.155, 175 An example of this was by Hu and 
colleagues. They synthesized GOx@ZIF-8 and HRP@ZIF-8 under a microfluidic flow. The 
activity was enhanced drastically when the protein was added after pre-synthesis of ZIF-8 seed 
crystals. This was attributed to the formation of a protein@ZIF-8 layer close to the outer surface 
of the MOF allowing for faster diffusion of reactants to the enzymatic active sites.175 
Furthermore, the MOF shape and pore structure can impact the materials overall activity. For 
instance, Cui and colleagues synthesized catalase@ZIF-8 with a crucifix-like morphology. 
This material had a higher loading efficiency (LE) and activity when compared to a rhombic 
dodecahedral (RD) equivalent.176 Recently, Wu and colleagues managed to synthesize a 
GOx@ZIF-8 complex that was amorphized. The complex retained a LE of ~10%, similar to 
standard RD GOx@ZIF-8. However, this complex had a 20-fold improvement on the activity 
when compared to RD GOx@ZIF-8.177 
Unfortunately, morphological control of MOFs is difficult. Furthermore, the addition of 
protein during synthesis further complicates this challenge. In the Doonan group’s initial 
biomineralization study using ZIF-8, they observed a range of different morphologies when 
they encapsulated different proteins. These include: RD, truncated rhombic dodecahedron 
(TRD), nanoleaf, nanoflower, and cubic crystals. Furthermore, these samples ranged from 400 
nm to several μm in size. This led to the conclusion that the protein structure plays a substantial 
role in the sequestration of MOF precursors and the overall MOF morphology.149 To further 
investigate this effect, they encapsulated the 20 natural amino acids. They found that the crystal 
size and shape varied substantially depending on the charge of the amino acid. ZIF-8 was not 
formed at all when lysine, arginine, or histidine were added. This was attributed to the basic 
side groups of these amino acids being unable to sequester zinc(II) ions.166 This is in strong 
agreement with their 2018 study on the impact of the protein isoelectric points (pI) on the 
formation of protein@MOF complexes. They found that proteins with lower pI values were 
more likely to be successfully encapsulated within ZIF-8. Furthermore, by applying a negative 
surface charge to a protein, biomineralization could be induced. For instance, haemoglobin (pI 
= 7.0 – 8.1) does not induce ZIF-8 biomineralization. However, haemoglobin succinylation 
70 
 
allowed a heamoglobin@ZIF-8 complex to form.178 However, given potential risks of 
denaturing delicate products by surface modification, which were not investigated, it is unlikely 
this strategy is generally feasible or facile.  
Whilst the protein selection impacts the MOF morphology this is not the only influence. In 
fact, in 2017, Cui and colleagues found they could not identify a correlation between protein 
structure and MOF morphology during ZIF-8 synthesis. They synthesized ZIF-8 with a high 
HmIM concentration (0.7 – 1.0 M). This resulted in the formation of a crucifix morphology. 
This same morphology was achieved when synthesized with no protein, lipase, HRP, trypsin 
and GOx. They concluded this result was in contradiction with the conclusions drawn by the 
Doonan group.176 However, a further study by the Doonan group concluded that the growth 
trends of ZIF-8 remain the same regardless of protein selection. However, different proteins 
tended to form different morphologies and topologies using lower Zn/HmIM concentrations.179 
Therefore, it could be the differing effect of proteins in these studies is not contradictory. 
Rather, it may just be the impact of investigating the biomineralization effect while using 
substantially different Zn/HmIM concentrations. Nevertheless, significant work is still required 
before rational morphology control of protein@ZIF-8 samples can be achieved.  
3.1.1.2.2. Protein@MOF Nanoparticles  
The formation of protein@MOF NPs is particularly valued for two predominant reasons. 
Firstly, these complexes are often used for drug delivery.44, 180, 181 For instance, Duan and 
colleague synthesized ZIF-8 encapsulating insulin and GOx (insulin/GOx@ZIF-8). This 
material has significant promise for reducing the risk of insulin overdose in diabetic patients. 
During standard treatment, the patient’s blood glucose must be continuously monitored, and 
insulin must be injected during spikes. However, with insulin/GOx@ZIF-8, the GOx catalyses 
the production of hydrogen peroxide in the presence of glucose. This causes the degradation of 
ZIF-8 and the release of insulin. Therefore, insulin is only released during a glucose spike.180 
Unfortunately, as discussed before (1.1.4.2 Drug Delivery), the distribution of MOFs in vivo 
during drug delivery is highly dependent on their morphology.  
The second advantage of producing protein@MOF NPs is that by reducing the NP 
dimensions the time taken for substrates to diffuse through the MOF to enzymatic active sites 
decreases. Generally this increases the activity of the overall complex.69, 159 This has been 
known to increase the activity of these complexes. There are two notable existing strategies to 
tune the size of protein@ZIF-8 complexes in situ. Both strategies synthesized bovine serum 
albumin (BSA)@ZIF-8. In the first case, Chen and colleagues increased the ligand to metal 
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ratio to 70:1. They managed to synthesize BSA@ZIF-8 NPs ranging in size from 60 to 138 nm 
depending on the BSA concentration.44 In the latter case, the Doonan group synthesized 
BSA@ZIF-8 ranging from 40 to 100 nm by varying the flow rate in a specialized continuous 
flow apparatus.182 Unfortunately, whilst BSA is a cheap protein useful for modelling 
protein@MOF behaviour it does not possess enzymatic activity. Therefore, the impact of MOF 
size on activity could not be determined in either study.  
3.1.1.3. Microemulsion Synthesis 
Microemulsions can be highly biocompatible environments for synthesis since they prevent 
protein aggregation and improve their stability. In fact, microemulsions have already seen 
usage for the delivery of proteins.183, 184 Thus, suggesting proteins can be retained in 
microemulsions without denaturation. This was highlighted by Perinelli and colleagues. They 
demonstrated that BSA could maintain its native-state without denaturing in a Tween-80 w/o 
microemulsion for 6 months.185 Given their biocompatibility and usage for size-controlled 
MOF synthesis, microemulsions appears to be an ideal candidate environment for 
protein@MOF synthesis. However, microemulsion synthesis has only been used for 
protein@MOF synthesis on one occasion. This was by Chulkaivalsucharit and colleagues in 
2018.69 They encapsulated HRP in ZIF-8 using a BRIJ-C10 w/o microemulsion. Three 
different samples were produced using zinc nitrate concentrations of 0.25, 0.5 and 1.0 M and a 
M:mIM ratio of 1:4. The resulting samples had a uniform spherical morphology with a 30 nm 
radius and an activity enhancement when compared to the free enzyme in solution.69 Whilst 
this work is promising, much of the potential benefits of this technique have yet to be explored. 
This includes the potential to tune the composite size, control its morphology and encapsulate 
different proteins.  
3.1.2. Research Outline 
In this chapter, the applicability of microemulsion synthesis was explored using the 
techniques developed in Chapter 2 - Zeolitic Imidazole Framework Synthesis in 
Microemulsions. Specifically, the focus was placed on ZIF-8d-30 and various proteins added 
to the aqueous phase of μEL before synthesis. The main objectives of this study were to: 
1. Evaluate whether microemulsion synthesis could be used to encapsulate proteins in 
ZIF-8. 
2. Evaluate whether the inclusion of proteins impacts the MOF morphology. 
3. Evaluate whether the morphology of these protein@ZIF-8 complexes is tuneable.    
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To achieve these goals BSA and bovine haemoglobin (BHG)(Figure 3.3) were encapsulated in 
ZIF-8. For characterization, we used a combination of a UV-Vis Bradford assay and Fourier 
transform infrared (FTIR) spectroscopy in addition to the standard protocols outlined in 
Chapter 2 - Zeolitic Imidazole Framework Synthesis in Microemulsions. BSA was selected for 
encapsulation because it is a common, cheap and readily available protein that has previously 
been used as a model protein for testing encapsulation methods. BHG was used to test 
microemulsion synthesis of protein@ZIF-8 because its high pI (~8.2) makes it difficult to 
encapsulate in situ. Additional information on the structure of these proteins can be found in 
the supporting information (Table C.1) 
 








3.2. Results & Discussion 
3.2.1. Protein Quantity 
BSA@ZIF-8 was synthesized using the standardized protocol from Chapter 2 - Zeolitic 
Imidazole Framework Synthesis in Microemulsions (ZIF-8d-30 ) where 2.5 mg, 5 mg and 10 
mg of BSA was added per mL of μEL aqueous phase during synthesis (denoted BSA@ZIF-8-
BSA quantity e.g. BSA@ZIF-8-10). These samples were then treated with sodium dodecyl 
sulphate (SDS), a denaturing surfactant used to remove proteins from a composite’s surface.44, 
165 
The synthesis of ZIF-8 was confirmed using PXRD and FTIR (Figure 3.3A&B). The 
sample PXRD patterns were consistent with sod ZIF-8, indicating that protein addition did not 
alter the MOF morphology. Furthermore, all samples possessed peaks corresponding to C=N 
stretching modes (1580 cm-1), and out of plane (757 cm-1) and in plane (995 and 1309 cm-1) 
bending of an imidazolate ring. This is consistent with ZIF-8 or its mIM ligand. In addition to 
this, BSA possesses two peaks at ~1540 and ~1660 cm-1 from the amide I and II bands.186 The 
amide I and II bands result from the combination of multiple vibrations of the amide bonds of 
a protein’s backbone. For amide I, this is predominantly C=O and C-N stretching vibrations 
with minor contributions from N-H out of plane bending. For amide II, this results 
predominantly from in-plane N-H bending and C-O stretching with minor contributions from 
C-O, N-C and C-C stretching vibrations. The amide II band is clearly present in all BSA@ZIF-
8 samples indicating the successful inclusion of BSA.187 Because the samples were SDS treated 
these peaks are due to encapsulated BSA rather than BSA coating the surface of the ZIF-8 
crystals. This was confirmed by independently surface coating ZIF-8 crystals with BSA and 
performing the same treatment on the surface coated BSA#ZIF-8 crystals. Before SDS 
treatment was performed BSA#ZIF-8 crystals possessed both amide I and II peaks which were 




Figure 3.4 (A) PXRD and (B) FTIR BSA@ZIF-8 synthesized with different quantities of 
BSA. 
To determine the protein LE (A.4.2 Loading Efficiency), a Bradford assay was used. In this 
assay, Bradford reagent was added to the digested protein@MOF composite. Bradford reagent 
contains Coomassie Blue G-250 which binds to the amino and aromatic groups of proteins in 
acidic conditions (pH > 5). This causes a shift in the dye’s UV-vis absorption peak from 465 
to 595 nm.188 Measuring the absorptivity allows the amount encapsulated protein to be 
quantified by comparison to a standard curve (Figure B.8). The LE was 0.91, 4.77, and 17.1% 
for the 2.5, 5 and 10 mg samples, respectively. This result arrives at the unremarkable 
conclusion that if more protein is introduced more protein is encapsulated. Interestingly, in the 
scope of in situ literature, these values are unremarkable since protein@MOF complexes have 
been formed with LE values as high as 21.2%.69 However, this is atypical and multiple studies 
consider LE values less than 10% as acceptable.150, 151, 164, 172 In one such study by Gascon and 
colleagues, LE values ranged from 10.0% at maximum for alcohol dehydrogenase@FeBTC to 
0.1% for GOx@ZIF-8.172  In the context of BSA@ZIF-8, the LE value of 17.1% is remarkably 
high. Typical BSA@ZIF-8 LE is ~5%.44, 182 The encapsulation efficiency* (A.4.3. 
Encapsulation Efficiency) of the 2.5, 5 and 10 mg samples were 4.3%, 7.26%, and 18.1%. In 
all three cases the encapsulation efficiency is relatively low. However, it should be noted that 
these calculations were based on the final yield of product after SDS washing which was 19.0, 
13.7, and 21.3 mg respectively. It should be noted substantially higher yields are observed 
before this procedure. For instance, the synthesis of pure ZIF-8 using the microemulsion 
 
* The mass protein encapsulated as a percentage of protein added during synthesis 
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method, from which these synthesizes are derived (ZIF-8d-30), yields 43 mg of product. 
Synthesis of the 10 mg BSA@ZIF-8 sample yields 55 mg before SDS washing. As the mass 
loss during SDS washing is greater than the amount of protein added during synthesis it is 
reasonable to conclude a substantial portion of the crystals were also resuspended in the 
solution and not recollected during this step. It is worth noting, that when SDS washing is 
employed in the literature the idea this may cause resuspension of the crystals is generally not 
considered, though the crystals this technique have been applied to are far larger and less likely 
to get resuspended.149 Accounting for this procedural fault, the encapsulation efficiency could 
be as high as 52.3%. This is not high but is with in a reasonable nominal range. 150, 151, 164, 172 It 
is worth noting that the encapsulation efficiency appeared to have increased as the amount of 
protein added increased. It is not obvious why this would be the case.  
The morphology of BSA@ZIF-8 samples was assessed using TEM (Figure 3.4). In all 
cases, distinct RD crystals were observed. Surprisingly, no correlation was observed between 
the NP size and the amount of protein added. The 0 mg sample (ZIF-8d-30) possessed an 
average NP size of 74.5 ± 17.9 nm (N = 108). This decreased to 58.0 ± 15.7 nm (N = 132) for 
the 2.5 mg sample. The RSD was consistently with all samples between 21.6 and 27.1%. For 
the 5 mg sample, the average NP size was 82.3 ± 21.7 nm (N = 113). For the 10 mg sample, 
the average NP size was 69.7 ± 15.1 nm (N = 103).  It should be noted that unlike other chapters 
all sample PSDs in this chapter  could be modelled with a standard Gaussian distribution (Table 
B.4). Surprisingly, this is consistent with the results from chapters 2 & 4, where all samples 
possessed a Gaussian distribution except for the smallest samples studied. The purpose of this 
chapter was not to develop a synthetic protocol for the smallest protein@ZIF-8 NPs. Rather, 
the objective was to investigate whether the size and shape trends observed in Chapter 2 - 
Zeolitic Imidazole Frameworks hold true when protein is added during synthesis. The modified 
conditions which produced the smallest ZIF-8 sample (an addition time of 0 min, ZIF-8b-0) 







Figure 3.5 Weibull modelled PSD displaying the (A) PDF and (B) CDF of ZIF-8 
synthesized with variable BSA quantities. Individual data points show the ECDF. TEM 
images of BSA@ZIF-8 synthesized with (C) 0, (D) 2.5, (E) 5, and (F) 10 mg BSA. The scale 
bar is 200 nm.  
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3.2.2. Addition Rate 
From previous research, it was found that altering the addition rate alters the size of ZIF-8 
crystals (2.2.3 Addition Rate). Therefore, the question of whether addition rate could be used 
to tune particle morphology was investigated with BSA@ZIF-8. Hence, BSA@ZIF-8 was 
synthesized using three different addition times (15, 30 and 120 min) (samples BSA@ZIF-8b-
time). Sample BSA@ZIF-8c was used as the 30 min sample. PXRD and FTIR of all three 
samples was consistent with the formation of sod ZIF-8 encapsulating BSA (Figure 3.6).  
 
The Bradford assay determined LE for each sample was relatively consistent regardless of 
addition time. At 15 minutes, the LE was 12.5%. This increased to 17.1 and 17.7% for the 30 
min and 120 min addition times. Interestingly, this suggests that slow addition leads to 
sequestration of more protein. The encapsulation efficiency of the 15, 30, and 120 min samples 
were  10.8%, 18.1% and 13.9%. Though it should be noted this is subject to the same 
experimental error observed in 3.2.1. Protein Quantity. 
The sample morphology of all BSA@ZIF-8 samples was generally RD (Figure 3.4C-E). 
The 120 min BSA@ZIF-8 appears to also possess some cubic crystals. In comparison, pure 
ZIF-8 had RD morphology for only the 120 and 30 min samples and the 15 min ZIF-8 sample 
had a psuedospherical morphology (Figure 3.6F-H). As the addition time increased, the 
BSA@ZIF-8 composite size increased. For the 15 min samples, the NP size increased from 
 
Figure 3.6 (A) PXRD and (B) FTIR of BSA@ZIF-8 synthesized with variable addition 
times. 





























          ZIF-8     BSA@ZIF-8 (          15 min           30 min          120 min )         BSA
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52.7 ± 14.4 nm (N = 102) to 69.7 ± 15.1 nm (N = 103). For the 30 min samples, little difference 
was observed in either the average particle size or SD. Pure ZIF-8 was 74.6 ± 18.0 nm (N = 
107) whereas BSA@ZIF-8 was 72.2 ± 17.0 nm (N = 119). For the 120 min samples, ZIF-8 was 
87.3 ± 22.4 nm (N = 131) and BSA@ZIF-8 was 87.6 ± 24.5 nm (N = 108). Notably the trend 
in BSA@ZIF-8 NP size is the same as that of pure ZIF-8 suggesting the addition rate can be 






Figure 3.7 Weibull modelled PSD displaying the (A) PDF and  (B) CDF of BSA@ZIF-8 
samples synthesized with a variable addition time. Individual data points show the ECDF. 
TEM images of BSA@ZIF-8 synthesized with a (C) 15, (D) 30, and (E) 120 minute addition 
time. TEM images of ZIF-8 with a (F) 15, (G) 30, and (H) 120minute addition time. The 
scale bar is 200 nm. 
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3.2.3. Bovine Haemoglobin  
In this section, the encapsulation of bovine haemoglobin (BHG) was attempted. BHG 
encapsulation was attempted for two reasons. The first was that different proteins can behave 
differently when encapsulated. Hence, BHG was used as a model protein to investigate how 
the addition rate influences the morphology of a complex other than BSA@ZIF-8. Secondly, 
haemoglobin@ZIF-8 is notoriously difficult to produce. This is attributed to it possessing a net 
positive surface charge. Hence, it struggles to sufficiently sequester Zn2+ ions for 
biomineralization.178  Only two studies have synthesized it: both by the Doonan group.149, 178 
In the first study, BHG@ZIF-8 was synthesized using a standard biomimetic mineralization 
protocol.149 However, through correspondence with Natasha Maddigan (a current Doonan 
group member), it was found that replication issues occurred during this synthesis and very 
few crystals were obtained with poor crystallinity. This suggests the present ZIF-8 crystals 
grew around some form of contaminant or trace quantities of haemoglobin in the original study. 
In the later study, haemoglobin@ZIF-8 was synthesized. However, surface modification of 
haemoglobin was required to achieve this result.178 
In the previous sections (3.2.1 Protein Quantity & 3.2.2Addition Rate), BSA@ZIF-8 was 
synthesized with a high LE of ~17%. This was attributed to the localized confinement of BSA 
and the ZIF-8 precursors within the microemulsion. If that is the case, an aqueously soluble 
protein with a low binding affinity for ZIF-8 precursors could be encapsulated by confinement 
within the same micelle as the growing crystal. Hence, BHG encapsulated within ZIF-8 was 
attempted using three different addition times (15, 30, and 120 min) during synthesis. These 
were denoted BHG@ZIF-8-addtime e.g. BHG@ZIF-8-15.  
PXRD patterns and FTIR spectra of all samples was consistent with sod ZIF-8. 
Furthermore, the amide II band is present in all samples even following SDS washing (Figure 
3.7A& B). Pure ZIF-8 was surface coated with BHG. No amide II peaks were present in the 
surface coated sample after SDS washing (Figure B.7). Therefore, the presence of the amide II 
band in BHG@ZIF-8 samples indicates the successful encapsulation of BHG in all samples.  
From the TEM images all BHG@ZIF-8 samples were determined to have a RD 
morphology (Figure 3.7C-G &). This is consistent with the behaviour of BSA@ZIF-8 using 
the same addition times. Interestingly, the TEM images show an increased tendency for 
BHG@ZIF-8 crystals to aggregate as the addition time decreased. This is understandable since 
smaller crystals tend to aggregate due to having a large outer surface area to volume ratio. At 
15 min, BHG@ZIF-8 was produced with an average size of 55.9 ± 22.4 nm (N = 105). This is 
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larger than the equivalent ZIF-8 sample but smaller than the equivalent BSA@ZIF-8 sample. 
For the 30 min and 120 min samples, BHG@ZIF-8 syntheses consistently produced smaller 
crystals than their ZIF-8 and BSA@ZIF-8 counterparts (Table B.5). At 30 min, the BHG@ZIF-
8 size was 62.6 ± 21.7 nm (N = 107). At 120 min, the size was 75.3 ± 29.9 nm (N = 103). The 
BHG@ZIF-8 size follows the general trends observed with ZIF-8 and BSA@ZIF-8. As the 
addition time increases the NP size increases. Therefore, it is likely that addition time control 
can be used generically to tune the size of protein@ZIF-8 complexes within this microemulsion 
system. However, it should be noted, that adding BHG during synthesis substantially increased 
the dispersity of the resulting crystals. The BHG@ZIF-8 RSD ranged from 34.7 to 40.0. In 
Chapter 1 - Introduction, samples were considered to have a reasonably low dispersity if the 
RSD was below 45%. These samples fulfil this requirement. However, these samples possess 
the three largest RSD values of any sample in this thesis, except ZIF-8a-1x (RSD = 45.5%) 
(Chapter 2 - Zeolitic Imidazole Framework Synthesis in Microemulsions). ZIF-8a-1x was 
specifically noted for having a broad PSD because it was an early stage unsuccessful ZIF-8 







Figure 3.8 (A) PXRD and (B) FTIR of BHG@ZIF-8 samples. (C) Weibull modelled PDF 
of sample PSD. (D) Weibull CDF of BHG@ZIF-8 PSD. Open dots represent the ECDF. 
TEM images of (E) BHG@ZIF-8-15, (F) BHG@ZIF-8-30, and (G) BHG@ZIF-8-120. 
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3.3. Future Work 
Obtaining the LE of BHG@ZIF-8 complexes is an important area of future work required 
to complete this study. However, due to time constraints this was not finished. Another useful 
area of future work is investigating the activity of protein@ZIF-8 complexes. The two proteins 
investigated thus far (BHG and BSA) have no enzymatic activity. The role of this study was to 
investigate the morphological properties of the protein@MOF complexes formed. However, 
this does not consider the conformational changes a protein may undergo during encapsulation. 
A complex with a high LE would be functionally useless if the protein was denatured during 
the encapsulation process. To investigate the enzymatic activity of these complexes an enzyme 
should be encapsulated (e.g. HRP, or GOx) and characterized.  
3.4.Conclusion 
In this chapter, it was demonstrated that microemulsion synthesis could be utilized to 
synthesize BSA@ZIF-8 NPs. The resulting materials had high LE values up to ~17%. 
Furthermore, the particle size could be finely tuned from 69.7 ± 15.1 to 87.6 ± 24.5 nm by 
adjusting the addition time. All samples had a relatively consistent RSD between 21.6 and 
27.9%. Microemulsion synthesis was then applied to synthesize BHG@ZIF-8 crystals. BHG 
was successfully encapsulated despite its significant difficult in the literature. This marks the 
first facile and reproducible approach to synthesize this protein@MOF complex. Furthermore, 
like BSA@ZIF-8 and ZIF-8 the NP size could be tuned by modifying the addition time. Thus, 
marking this approach as a potentially generic method to produce tuneable sized protein@ZIF-
8 NPs. Further work should be done to obtain the LE of BHG@ZIF-8 and to encapsulate an 
active enzyme e.g. β-glucosidase or HRP. 
3.5. Experimental Methods 
3.5.1. Materials 
As per section 2.4.1. Materials, all chemicals and reagents were sourced from commercial 
suppliers at a purity of 99.8% or greater and used without further purification. Protein samples 
were acquired as lyophilized powders.  
3.5.2. Synthesis Procedure 
Protein@MOF complexes were synthesized using the method outline in 2.4.2 
Microemulsion ZIF-8 for sample ZIF-8d-30 with minor variation. The aqueous phase of μEL 
was prepared with a variable concentration of either BSA or BHG. The addition time where 
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μEL was added to μEM was also varied. The composition and addition time for individual 
samples is provided in Table 3.1.  
Table 3.1 Microemulsion Synthesis of Protein@ZIF-8 samples 
Sample Protein Addition Time (min) 
Type Quantity 
(mg mL-1)* 
BSA@ZIF-8a-2.5 BSA 2.5 30 
BSA@ZIF-8a-5 BSA 5 30 
BSA@ZIF-8c BSA 10 30 
BSA@ZIF-8b-15 BSA 10 15 
BSA@ZIF-8b-30 BSA 10 120 
BHG@ZIF-8-15 BHG 10 15 
BHG@ZIF-8-30 BHG 10 30 
BHG@ZIF-8-120 BHG 10 120 
 
3.5.3. Surface Protein Wash 
To wash the protein off the outer surface of the MOF, samples were dispersed in aqueous 
SDS (0.1 mL per 1 mg sample, 2 mM SDS). The samples were then heated to 70 oC for 10 min 
before centrifugation (5000 rpm, 10 min) and washing with water (3 x 0.1 mL per 1 mg)44. 
Samples were sonicated for ~5-10 s to resuspend them during SDS and water washing cycles. 
The samples were then lyophilized.  
3.5.4. Characterization Methods.  
Protein@MOF samples were characterized by the methodology below in addition to the 
characterization methods performed on ZIF-8 in 2.4 Experimental Methods.  
3.5.4.1. Bradford Assay 
Bradford reagent was prepared by dissolving Coomassie Blue G-250 in 95% ethanol (50 
mL, 2.34 mM). Phosphoric acid was then added (100 mL, 85% w/v). The mixture was then 
diluted to one litre in water, before filtering through Whatman paper to remove the precipitate. 
The solution was then stored at 4 oC until further use. Bradford reagent was warmed to room 
temperature before use.  
 




 For Coomassie Blue G-250 to bind BSA, ZIF-8 must be degraded to release BSA. This 
was achieved by dissolving the ZIF-8 sample (1 mg) in aqueous HCL (0.1 M, 1 mL). Sample 
standards were prepared by digesting pure ZIF-8 in HCL as per previous digestion instructions. 
BSA was added to the digestion mixture at various concentrations (0 – 10 μg mL-1, 1 μg mL-1 
increments). 
Bradford reagent (3 mL) was added to digested protein@ZIF-8 samples (0.1 mL). Sample 
absorption was measured at 595 nm using a Shimadzu UV-1800 spectrophotometer running 
UVProbe version 2.62 software. The protein concentration was calculated by comparison to a 
linear fitted standard curve. The LE was calculated as specified in the appendix (A.4.2 Loading 
Efficiency).  
3.5.4.2. FTIR 
IR data was collected using a Thermo Scientific Nicolet iS5 infrared spectrometer with an 
iD7 diamond crystal ATR attachment. Transmittance FTIR spectra were collected using 





Chapter 4 -  Microemulsion Synthesis of UiO-66 
4.1. Introduction 
Synthesized in 2008 by the Lillerud group,189 UiO-66 (Universitetet i Oslo*) is widely 
considered the archetype of the zirconium carboxylate MOFs; a MOF subclass regarded highly 
for their high stability and crystal defects (4.1.1 Crystal Defects). This has allowed them to 
become one of the most studied MOF subcategories in the literature.190 UiO-66 consists of 
Zr6O4(OH)4
12+ octahedral clusters bound to 12 BDC ligands with an overall formula of 
Zr6O4(OH)4(BDC)6. This is arranged as a face centred cubic fcu net with Fm3̅m symmetry 
(Figure 4.1). The high connectivity of this structure results in UiO-66 being one of the most 
stable MOFs in the literature. It can withstand temperatures up to 500 oC and significant 
mechanical stress.190  Furthermore, it can retain its structure in a wide range of solvents 
including water, DMF, and benzene.189  
 
Figure 4.1 Cubic arrangement of UiO-66 with [Zr6O4(OH)4(BDC)12] clusters. 
  
 
* Norwegian: University of Oslo 
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4.1.1. Synthesis Methods 
Originally, UiO-66 was synthesized by mixing ZrCl4 with H2BDC in DMF and heating at 
120 oC in the oven for 24 hours. This resulted in low quality crystalline aggregates.189 The issue 
of synthesizing reproducible high-quality crystals was solved by Behrens’ group in 2011.  They 
added carboxylate modulator (benzoic/acetic acid) to compete with BDC for binding sites. This 
approach slowed growth time allowing for the synthesis of larger more well-defined crystal. 
Furthermore, UiO-66 crystals were size tuneable from 122 to 458 nm by simply increasing the 
modulator ligand equivalents from 0 to 30.191 Modulated solvothermal synthesis has become 
the standard protocol for UiO-66, though different research groups tend to use their own 
inhouse variants. However, this method is not without issues. The introduction of modulators 
introduces crystal defects into the material, leading to expansive research into methods to 
control their defectivity (4.1.1 Crystal Defects). The use of organic solvents like DMF is both 
environmentally hazardous and costly.192, 193 High temperature syntheses limit the 
incorporation of thermally sensitive materials into the MOF.14, 193 The long growth period 
ranging from 1 to 4 days is non-ideal. These factors along with the pursuit of precise size-
controlled synthesis of nanoscale MOFs (4.1.3 Morphology) has driven further development 
into new UiO-66 synthesis methods including MW/US,194-196 electrochemical197 and 
mechanosynthesis.198, 199 A full review of all UiO-66 synthetic methods would be well beyond 
the scope of this thesis.  
Significant advances have been made towards environmentally friendly UiO-66 synthesis 
through the development of mechanosynthesis and ambient temperature hydrothermal 
synthesis. Mechanosynthesis involves the introduction of the metal and ligand by grinding 
mechanisms such as ball milling or liquid assisted grinding. However, such methods are often 
complex and result in poor quality crystals in low yields. An alternative approach has been to 
develop methods to synthesize UiO-66 in aqueous or ambient conditions. However, this has 
been an ongoing challenge for several reasons. Firstly, H2BDC is insoluble in aqueous 
conditions. Secondly, the presence of water can induce defects in the final crystal (4.1.2 Crystal 
Defects). Finally, room temperature syntheses often result in materials with low porosity and 
pore crystallinity. A breakthrough in this regard was achieved by Farha’s group in 2016, when 
they successfully synthesized UiO-66 at room temperature in DMF from the pre-synthesized 
metal clusters. They pre-synthesized the Zr(O)4(OH)4(CH3COO)12 cluster by reacting the 
zirconium salt with acetic acid (1:443 equivalents) at temperatures between 40 and 120 oC 
before substituting the acetic acid with BDC at room temperature.14 Another major milestone 
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was achieved by Zhao’s group in 2015 with the first aqueous synthesis of UiO-66. Furthermore, 
this required refluxing and unintentional defects were introduced into the crystal due to the 
heterogenous distribution of insoluble ligands in the solution hence H2BDC was functionalized 
with hydrophilic amine, alcohol and carboxylic acid groups, to iron out defects.192 These 
approaches were combined by Pakamore and colleagues in 2018 to allow for the first aqueous 
room temperature synthesis of a UiO-66 derivative. To achieve this, H2BDC was substituted 
with amino groups which was then solubilized by deprotonation in dilute NaOH. Meanwhile 
Zr(O)4(OH)4(CH3COO)12 clusters were pre-synthesized from ZrOCl2.8H2O using Farha’s 
method but substituting DMF for water. The two solutions were then mixed over a 24-hour 
period. Whilst promising, this method is only applicable to UiO-66-NH2 and not UiO-66 
itself.193 Attempts to replicate this synthesis using H2BDC result in a non-crystalline material 
(Figure B.7). To date, a room temperature, aqueous synthesis of UiO-66 has still not been 
realized.  
4.1.2. Crystal Defects 
The high connectivity and stability of UiO-66 suggests that it is possible for it to maintain 
its overall structure even when one or two linkers from its unit cell are lost. Indeed, this was 
confirmed in 2011 by Valenzano and colleagues. They reported that analysis of the thermal 
decomposition of UiO-66 suggested that less BDC was present in the structure then the 
idealized formula predicts. This was termed a missing linker defect200. At missing linker sites, 
the metal cluster is capped with water, hydroxide or carboxylate modulators replacing the 
absent ligand. A 2014 study by Goodwin’s group demonstrated that defects can also occur due 
to the loss of zirconium clusters and their surrounding ligands (missing cluster defects). 
Importantly, both missing linker and missing cluster defects result in a deficit of BDC.201 As a 
result of these defects, the typical fcu topology is altered to either bcu, scu, or reo at the 
afflicted sites (Figure 4.2). As of 2019, Liu and colleagues have confirmed the presence of 
these topologies by direct imaging using high resolution TEM. Where bcu is the result of 
missing linker defects, reo and scu result from missing cluster defects. However, reo and scu 
differ in the connectivity of the remaining clusters. The reo clusters are 8 connected whereas 
scu clusters are 4 connected.202  
Defectivity has a significant role in the material properties of UiO-66. The presence of 
defects reduces the thermal stability of the material. Furthermore, the BET surface area 
increases on the inclusion of defects. This was first observed in a 2013 study by Zhou and 
colleagues, who systematically increased the amount of missing linker defects causing a 32% 
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increase in the BET surface area.203 This has allowed researchers to synthesize UiO-66 with 
surface areas of up to 1890 m2g-1 despite the theoretical maximum surface area of ideal UiO-
66 being significantly less than this.204 Unsurprisingly, this significantly impacts the gas 
adsorption properties of guest molecules such as H2O and CO2 adsorption.
205, 206 This can also 
have significant impact on the drug loading. This was highlighted by Shan and colleagues when 
they loaded ferrocene into UiO-66. Analysis of the pore size distribution of the material 
demonstrated that ferrocene near exclusively occupied defect sites. This was attributed to 
greater accessibility due to the enhanced void space.204  
 
 
Figure 4.2 UiO-66 defects and corresponding topologies  
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Due to its impact on physical properties and applications, defect engineering has become a 
major field in UiO-66 research. One way this can be achieved is by altering the synthetic 
conditions. Whilst parameters such as reaction temperature, reaction time and the choice of 
metal salts have been shown to alter the defectivity, modulator-ligand competition has been 
highlighted as a primary contributor to crystal defects. Given that modulators bind the 
zirconium cluster in place of BDC, the presence of modulators result in missing linker defects. 
The greater the modulator to ligand ratio is the more competition exists for binding sites 
resulting in more defects. In addition, the acidity of the modulator plays a significant role as 
the zirconium clusters bind carboxylic acid groups in the deprotonated state. Modulators with 
lower pKa values will more likely exist in the deprotonated state creating greater competition.  
For this reason, equivalent UiO-66 synthesized with acetic acid (pKa = 4.76) will have fewer 
defects compared to a synthesis using equivalent amounts of trifluoracetic acid (pKa = 0.23). 
As zirconium clusters are also modulated by binding water molecules and hydroxide ligands, 
using more water during the synthesis will increase the defectivity of the overall material.207  
4.1.3. Morphology 
UiO-66 growth is typically oriented along the [111] crystal faces resulting in an octahedral 
morphology. However, cubic or cuboctahedron morphologies have also been observed due to 
growth of the [100] facet or a combination of [100]/[111] growth (Figure 4.3). This was 
highlighted by Han and colleagues managed to isolate these morphologies by adding HF during 
synthesis. The addition of HF slows growth along the [111] face.208 Furthermore, UiO-66 also 
forms amorphous aggregates, typically due to the presence of excess water during synthesis.191 
 
Figure 4.3 From left to right: octahedral, cuboctahedral, and cubic morphologies 
The NP size of UiO-66 has significant variability within the literature, ranging from 14 nm 
to 300 μm.191, 209 To date the smallest UiO-66 NPs (14 nm) were synthesized by Schaate and 
colleagues by adjusting the pKa and concentration of modulators during solvothermal 
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synthesis.191 To date, researchers have adjusted the NP size of UiO-66 through a variety of 
mechanisms. For instance, Zhao and colleagues managed to tune UiO-66 dimensions from 2 
μm to 500 nm by increasing the concentration of triethylamine used during solvothermal 
synthesis.210 However, adjusting such parameters also impacts the defectivity of the material, 
decoupling of these two properties is a major challenge UiO-66 crystal design. In 2019, Decker 
and colleagues investigated the simultaneous use of three properties to tune the particle size 
and defectivity: the water equivalence, ligand to metal ratio and the reaction time. Whilst this 
approach allowed control of both NP size (20-120 nm) and defectivity (0-12%), it did not allow 
independent control. A reduction in NP size was generally correlated with decreased 
defectivity.81 Hence, the rational design of UiO-66 NPs with a precise size and defectivity is 
still an ongoing challenge. 
4.1.4. Research Outline 
Like ZIF-8, the investigation of new methods to tune the morphology of UiO-66 is highly 
relevant because of UiO-66’s prevalence and the potential scope of its applications. However, 
microemulsion synthesis of UiO-66 represents a far more significant target, given the 
difficulties in producing ambient temperature or aqueous synthetic methods. The 
microemulsion synthesis method described in the previous chapters is significantly less 
environmentally harmful than typical solvothermal methods. Furthermore, MOF defectivity 
when synthesized within microemulsions has yet to be studied and UiO-66 is an ideal MOF for 
defectivity analysis. The objective of this chapter was to synthesize UiO-66 using the 
microemulsion method developed in Chapter 2 - Zeolitic Imidazole Framework Synthesis in 
Microemulsions and characterize the morphology and defectivity of these materials when 
synthesized with various conditions. To achieve this goal UiO-66 was synthesized with 
variable ωo and addition times. Characterization was performed as outlined in previous 
chapters. In addition, the surface area and pore size distribution were characterized using N2 
gas adsorption. Whereas the defectivity was determined using thermal gravimetric analysis 
(TGA). 
4.2.Results 
Microemulsion UiO-66 was synthesized using the method outlined in 4.4.1 Microemulsion 
UiO-66. The microemulsions were prepared with ωo values of 27.8, 22.3, and 16.7. Further 
samples were prepared with 11.1, 10 and 5.6 ωo. Though these latter three samples have not 
been fully characterized and this is an area of future research. These ωo values correspond to 
10, 8, 6, 4, 3.6, & 2 mL of water used during synthesis. For each ωo value, UiO-66 was prepared 
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with a 120 or 30 min addition time. The samples are denoted UiO-66-volume-addtime e.g. 
UiO-66-10-120.  
4.2.1. Topology 
The PXRD patterns of all samples (Figure 4.4A & B) displayed peaks matching simulated 
UiO-66. Samples possessed peaks at 2θ values of 7.3, 8.7, 14.9, and 25.6o. These matched the 
simulated UiO-66 peaks for the [111], [002], [222] and [006] planes. In addition to simulated 
peaks, UiO-66 samples can also possess Bragg peaks at 4.45 and 6.0o from the [001] and [011] 
reflections.202 These peaks occur due to correlated regions of reo defects that arise from 
missing linkers. Whilst no discrete peaks are identifiable, increased intensity is observed in all 
samples where these reflections would be expected. As all samples experience significant peak 
broadening, these peaks are not expected as they would be masked into a “broad peak” in this 
region.207 Hence, the intensity at 4.44o as a percentage of the 7.3o peak was determined to 
investigate possible trends in defectivity (Figure 4.4C & Table C.5). It was found that the 
relative intensity increases as the aqueous volume decreased. Furthermore, an increase in the 
relative intensity was observed when the addition time was decreased. For the 120 min samples, 
the relative intensity decreases from 4.8% to 37.5% between the 10 mL and 2 mL samples. The 
same trend is observed for the 30 min samples, where the relative intensity increases from 6.5% 
to 44.6% for the 10 mL and 2 mL samples. Furthermore, for both addition times a dramatic 
increase in relative intensity was observed for between the 4 mL and 2 mL samples.  
Another noticeable feature of the UiO-66 PXRD patterns is that they exhibit significant 
peak broadening (Figure 4.4D & Table C.6). Peak broadening occurs where there is a reduction 
in the number of units along a plane (loss of periodicity) or coherence in long-range ordering 
is lost due to crystal strain. In this case, loss of periodicity is more likely because the ambient 
synthesis conditions used are unlikely to cause significant crystal strain. The length of a 
periodic domain (grain size) can be determined using the Scherrer equation211 (A.1.1. Powder 
X-ray Diffraction)*. This was performed measuring the peak broadening of the [111], [002] 
and [006] peaks. Grain size was averaged from all peaks assuming an isotropic crystallite. As 
a general trend the grain size decreased as the water volume decreased. For instance, UiO-66-
10-120 exhibited a grain size of 16.3 nm which reduced to 10.4 for UiO-66-4-120. 
Furthermore, the 120 min addition time produced crystals with less peak broadening than the 
30 min synthesis, in all cases. The calculated grain size of UiO-66-10-120 and UiO-66-4-120 
 
* ZIF-8 samples reported a larger size and do not possess significant defectivity. Therefore, it possessed 
significantly less size induced broadening. Instrumental broadening from the diffractometer masks this effect; 
particularly with larger crystallites. For this reason, the Scherrer equation could not be reasonably applied to most 
ZIF-8 samples.  
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were 2.6 nm and 0.1 nm  larger than their 30 min equivalents. Unfortunately, this method could 
not be performed for the 2 mL and 3.6 mL samples because the [111] and [002] peaks merged. 
Reduced grain size suggests a decreased NP size or increased defectivity.212 Amongst all 
samples the greatest variance observed in the grain size between different PXRD peaks was 
4.7 nm with most samples varying by 2-3 nm. This is relatively consistent.  
 
Figure 4.4 PXRD of UiO-66 synthesized in microemulsions with variable aqueous volumes. 
Samples were synthesized with a 120 (A) or 30 (B) minute addition time. (C) Relative 
intensity of the PXRD at 4.44o of the 7.30o peak. (D) Grain size. Filled dots are the averaged 
values. Open dots represent values obtained by individual PXRD peaks. 
4.2.2. Morphology 
Through TEM imaging (Figure 4.5), it was observed that UiO-66 samples generally 
consisted of discreet NPs with a consistent psuedospherical morphology. The NP size decreases 
between 10 mL and 6 mL water volumes for both addition times. However, for 4 mL samples 
the resolution of the TEM was insufficient at the enhanced magnification required to image the 
samples. Whilst UiO-66-4-120 could be imaged and was consistent with this trend, UiO-66-4-
30 had poor image resolution and appeared to be amorphous. It should be noted that, 
cuboctahedron and spherical samples are difficult to distinguish through TEM of NPs as the 



















































































A                                                                                 B
C                                                                                 D
94 
 
limited size of the crystallites makes edges difficult to define. Thus, the possibility of the 
crystallites being cuboctahedron is left open. However, cubic and octahedral morphologies are 
more easily identified and do not appear to be present in these samples. At water volumes less 
than 4 mL, sample amorphization becomes apparent. For both the 3.6 mL and 2 mL samples, 
large amorphous low crystalline materials without discernible NPs are present. Another 
interesting feature found through TEM imaging is that all NP samples have some degree of 
agglomeration where NPs are clustered together.  This is likely the result of the small NP size 
(> 40 nm). As NP size decreases the outer surface area becomes a larger fraction of the total 
surface area. Hence, NPs have a larger exposed area to attract other NPs. It should be noted 
that agglomerations were excluded from size analysis using imaging software (A.1.2 
Transmission Electron Microscopy). 
Such agglomeration could rationalize the amorphization of the 2 and 3.6 mL samples. As 
the water volume decreases the NP size decreases until discreet NPs  are no longer formed. As 
the NP size decreases the outer surface of the NP becomes a larger fraction of the total surface 
area. With a larger exposed surface area to agglomerate NP agglomeration is encouraged. For 
the below 4 mL samples discreet NPs do not form instead partially formed NPs agglomerate 




Figure 4.5 TEM images of (A) UiO-66-10-120, (B) UiO-66-8-120, (C) UiO-66-6-120, (D) 
UiO-66-10-30, (E) UiO-66-8-30, (F) UiO-66-6-30 with a 100 nm scale. (G) UiO-66-4-120 
with a 50 nm scale. (H) UiO-66-3.6-120, (I) UiO-66-2-120, (J) UiO-66-4-30, (K) UiO-66-




One of the major objectives of this research was to determine the effectiveness of 
microemulsion synthesis as a NP size control technique. As such, the particle size and 
distribution of the UiO-66 samples were determined from the TEM images (Figure 4.6 & Table 
B.5). A reduction in NP size was observed when reducing the addition time from 120 min to 
30 min. This was consistent for all water volumes. However, the difference in average size 
between samples with equivalent conditions was minor. At maximum, the difference in average 
particle size was 5.0 nm observed between the 10 mL samples. The smallest difference 
observed was 2.1 nm between the 6 mL samples. This result is consistent with the results for 
ZIF-8 previously discussed (2.2.3 Addition Rate). The observed increase in NP size with an 
increased addition time was unsurprising since a reduction in the addition time would likely 
increase the nucleation rate.133 Due to agglomeration and amorphization, discreet NPs could 
not be identified in the 2 mL and 3.6 mL samples for both addition times as well as the 30 min 
4 mL sample. 
 
Figure 4.6 UiO-66 PSD from TEM images for the (A) 120 minute and (B) 30 minute 
microemulsion synthesized samples. Outset: Modelled Weibull distribution PDF of sample 
PSD. Inset: Modelled Weibull (line) and experimental raw data (dots) CDF. 
Another noticeable trend was that the average NP size decreased as the water volume 
decreased. Unlike the subtle variation induced by adjusting the addition times, altering the 
water volume dramatically reduced the NP size. For the 120 min samples, the average NP size 
was tuned from 31.0 ± 8.0 (N = 141 nm) for UiO-66-10-120 to 4.09 ± 1.05 (N = 107) nm) for 
UiO-66-4-120. With a 4.09 nm average particle size, UiO-66-4-120 is the smallest ever 
recorded UiO-66 sample. It has a length of approximately two unit cells, based on a unit cell 
parameter of a = 20.7 Å. It should be noted that the literature record of 14 nm was recorded by 
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PXRD,191 which generally underestimates the NP size with the presence of defects. Hence, the 
actual NP size is likely larger.  
Another notable feature of the PSD was the SD. For the 30 min samples, the percentage 
SD ranged from 16.9% to 29.5% with no obvious trends. Whereas for the 120 min samples, 
the SD increased as the average NP size increased. However, the percentage SD remained 
relatively consistent for all samples (between 24.3% and 26.8%). For UiO-66-4-120, this 
manifested as a SD of 1.05 nm (25.7% SD). Nonetheless, using a 120 min addition time, all 
NP containing samples displayed a highly uniform morphology. Furthermore, by varying the 
aqueous volume the NP size is tuneable without significantly altering the dispersity. For this 
reason, microemulsion synthesis appears to be an excellent technique for obtaining UiO-66 
NPs with desired sizes. 
The two smallest samples synthesized with the 120 min addition time (UiO-66-4-120 & 
UiO-66-6-120) did not conform to a Gaussian distribution but did conform more closely to a 
Weibull distribution (Figure 4.7). This was previously observed with the smallest ZIF-8 
samples (Chapter 2 - Zeolitic Imidazole Framework Synthesis in Microemulsions). This result 
was attributed to lower tail inaccuracy of the Gaussian distribution due to instability of NPs 
below a critical nuclei radius. The NP size of UiO-66-4-120 for a Weibull distribution was 4.08 
± 1.14 nm (N = 107, RSD = 27.9%). The NP size of UiO-66-6-120 for a Weibull distribution 






Figure 4.7 UiO-66 PSD from TEM images for the (A) 120 minute and (B) 30 minute 
microemulsion synthesized samples. Outset: Modelled Weibull distribution PDF of sample 
PSD. Inset: Modelled Weibull (line) and experimental raw data (dots) CDF. 
4.2.3. Defectivity  
The presence of defects and the thermal stability of the UiO-66 samples were determined 
by TGA analyses in air (Figure 4.8 & Table B.6). Decomposition of UiO-66 was observed in 
two temperature ranges (~200-300 & ~500oC). These correspond to the two steps typically 
associated with UiO-66 decomposition. From the first derivative curves (Figure 4.7C& D), it 
was determined that the first decomposition step ends prior to 375 oC and the second step has 
ended completely by 550 oC. The residual material left in the TGA pan at 550 oC was assumed 
to be ZrO2. The percentage decomposition of BDC was ascertained from the weight loss 
between 375 oC and 550 oC. For the 120 min samples, the percentage of missing linkers 
decreased consistently from 17.5% for UiO-66-10-120 to 12.9% for UiO-66-8-120 and finally 
11.2% for UiO-66-6-120 (A.3.1 Total Defects). The 30 min samples generally had more 
missing linkers than the equivalent 120 min sample. The percentage defects were 21.8, 28.5 
and 22.5% for UiO-66-10-30, UiO-66-8-30, and UiO-66-6-30 respectively. Whilst, the 30 min 
samples possessed more defects, no obvious correlation between water volume and defectivity 
was observed. The range in defectivity across all samples is between 11.2 and 28.5%. This is 
an absence of 0.672 to 1.71 of the 6 ligands  per unit cell that would be expected in non-
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defective UiO-66.This is consistent with a typical defectivity range observed in the literature.14, 
193, 207  
Interestingly, the decomposition temperature varied slightly with the sample. The 
dehydroxylation of UiO-66 occurs for 120 min samples at ~300 oC. Whereas for 30 min 
samples, this appears to be a convolution of two steps at ~230 and 280 oC. It is unclear why 
this occurs, but it could be instrumental error. For the linker decomposition step there does not 
appear to be any correlation between particle size or defectivity with the decomposition 
temperature in the 120 min samples. For the 30 min samples, the decomposition temperature 
decreases from 501 to 490 oC from UiO-66-10-30 to UiO-666-30. This broadly corresponds 
with the decrease in NP size. There does not appear to be any correlation between the NP size 
and defectivity with the change in the BDC decomposition temperature. This is likely because 







Figure 4.8 TGA normalized against the ZrO2 plateau for 120 min (A) and 30 min (B) 
samples and their corresponding 1st derivative curve (C&D). Dotted lines show 100% and 
220% normalized mass. 
Notably, small NPs may not necessarily possess the ideal amount of BDC, even if the 
crystal possesses no internal defects. This is because they have a larger surface area to volume 
ratio. Hence, the absence of ligands on the surface due to network termination (a completely 
different phenomenon to the absence of ligands from the framework itself) contribute more 
significantly. The percentage of surface defects as a function of the NP size was modelled for 
UiO-66 (Figure 4.9). The model derivation can be found in the appendix (A.3.2 Surface 
Defects). The model assumes that the morphology is octahedral and that the entire outer surface 
is charge neutral. Both assumptions potentially overestimate the percentage surface defects.  
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Therefore, the defectivity present in each sample cannot solely be attributed to surface defects. 
Hence, analysed samples must possess missing linkers within their interior.  





































Figure 4.9 Modelled percentage of surface defects in UiO-66 as a function of NP size (black) 
along with experimental samples (red). 
4.2.4. Gas Adsorption Properties 
Gas adsorption of UiO-66 (Figure 4.10A&B) samples showed a decreasing surface area 
as the water volume and addition time decreased. For the 120 min samples, the BET surface 
area was 1818, 1262, and 1183 m2g-1 for the 10, 8, and 6 mL samples, respectively. At 1818 
m2g-1, UiO-66-10-120 has a surface area well beyond the theoretical maximum of 1644 m2g-1 
for an idealized UiO-66 crystal.66 Similar surface areas have been achieved by researchers 
using UiO-66 samples with approximately the same degree of defectivity.207 For the 30 min 
samples, the BET surface area decreased to 1186, 1079, and 926 m2g-1 for the 10, 8, and 6 mL 
samples. This trend is also apparent in the total pore volume. For the 30 min samples, the total 
pore volume decreased from 1.19 to 0.97, and 0.87 cm3g-1 for the 10, 8, and 6 mL samples. For 
the 120 min samples, the total pore volume was 1.77, 1.11, and 1.2 cm3g-1 for the 10, 8, and 6 
mL samples. This is consistent with previous literature, suggesting that the surface area and 
pore volume decreases as the NP size decreases. Curiously, the surface area and pore volumes 
were consistently larger for the 120 min samples compared to the more defective 30 min 
samples. This is in contrast with the literature which suggests an increased surface area would 
be expected due to enhanced defectivity. This implies the NP size has a more substantial 
influence than defectivity on the absorption properties of the material. 
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For both the 120 min and 30 min samples, a peak can be detected in the pore size 
distribution at 1.22 nm. This is consistent with the largest of the two micropores that exist in 
UiO-66. For each sample sets further peaks are visible for mesopores ranging from ~3.4 nm to 
25 nm that would not be present in simulated UiO-66. Such mesopores can exist due to defects 
in the crystals or interstitial void. Interstitial voids occur due to agglomeration of multiple 
crystals leaving a void space between them.66 UiO-66-10-120 and UiO-66-10-30 NPs are 31.0 
and 26.0 nm respectively and are 17.5 and 21.8% defective. A NP of this size and defectivity 
could not possess a 15 nm average pore within the crystal. This leads to the conclusion that the 
mesopores are due to interstitial voids.  
 
 
Figure 4.10 N2 adsorption isotherm at 77 K measured for 120 min (A) and 30 min (B) 
samples.  Isotherms display raw data points (dots) along with the adsorption (solid lines) and 
desorption (dashed) curves. Pore size distribution of 120 min (C) and 30 min (D) samples 
estimated from the adsorption isotherms. 
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4.3. Discussion & Future Work 
A summary table of the characterization data is provided below (Table 4.1). It should be 
noted that both the TGA and PXRD show increased defectivity with a 30 min addition time. 
This is good agreement given both measurement measure different properties. The relative 
intensity of the reo region is proportional to the number of correlated reo defects. Whereas, 
TGA measures the amount of BDC lost regardless of its location within the sample.   
 
Table 4.1 Summary Table of UiO-66 Characterizations 
Sample Size (nm) Defects (%) SA (m2g-1)* V (cm3g-1)† 
PXRD 
 
TEM  PXRD TGA 
UiO-66-10-120 16.33 31.0 4.78 17.5 1818 1.77 
UiO-66-8-120 12.72 20.2 7.22 12.9 1262 1.105 
UiO-66-6-120 12.79 14.6 6.88 11.2 1183 1.20 
UiO-66-4-120 10.40 4.09 10.49 -- -- -- 
UiO-66-3.6-120 -- -- 16.92 -- -- -- 
UiO-66-2-120 -- -- 37.53 -- -- -- 
UiO-66-10-30 13.67 26.0 6.50 21.8 1186 1.19 
UiO-66-8-30 11.78 17.4 10.00 28.5 1079 0.97 
UiO-66-6-30 10.74 12.6 9.55 22.5 926 0.87 
UiO-66-4-30 10.26 -- 12.14 -- -- -- 
UiO-66-3.6-30 -- -- 23.76 -- -- -- 
UiO-66-2-30 -- -- 44.59 -- -- -- 
 
For samples UiO-66-3.6-120, UiO-66-3.6-30, UiO-66-2-120 and UiO-66-2-30, there is 
broad agreement between the TEM and PXRD data. The PXRD of these samples illustrates 
 
* Surface area 
† Total pore volume 
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that they possess significantly higher defectivity compared to all samples. This is highlighted 
by both the high relative intensity of the reo peak and the significant peak broadening apparent 
through the PXRDs. This is consistent with the TEM images which show large amorphous 
material with no discreet NPs. Such a material could form by highly defective prenucleation 
clusters aggregating. Notably the characterization of these could not be fully completed. 
Whilst, it would be interesting to confirm this hypothesis by TGA defect analysis of the 
resulting samples, poorly crystalline samples are not of any particular research interest. Given 
the available information a complete characterization of the 4 mL samples would be of 
significant interest given the small dimensions of the UiO-66 NPs present.  
This study demonstrated several features which are highly interesting in the field of UiO-
66 morphological control. Though, this was achieved only with a narrow range of ωo values. 
Firstly, NPs maintained a uniform pseudospherical morphology and a narrow size distribution. 
Second, the NP length could be rationally tuned between 31.0 to 4.1 nm by altering ωo values. 
This is consistent with many prior microemulsion studies. The 4.1 nm sample is the smallest 
recorded UiO-66 sample to date. This is promising for later studies investigating how NP size 
affects physical properties. Finally, particle size and defectivity appear to be uncorrelated. 
Further research is required to investigate potential factors that may alter the defectivity. If both 
the defectivity and NP size can be tuned individually the applicability of this technique for 
UiO-66 morphological control would be greatly enhanced. For instance, the 30 min addition 
time samples possessed significantly more defects than the equivalent 120 min addition time. 
Later studies should investigate whether longer addition times reduce defectivity. Another 
factor worth investigate in future studies is the pre-treatment heating of the ZnOCl2 solution. 
Before synthesis, the aqueous ZnOCl2 stock used during synthesis was heated to 60
oC with 
acetic acid. DeStefano uses this same pre-treatment procedure to prenucleation clusters for 
UiO-66 synthesis. The treatment temperature was varied from 45 oC to 130 oC and the 
defectivity changed from 1.3 to 0.2 missing linkers per unit cell.  The impact of treatment 
temperature on UiO-66 defectivity using the microemulsion synthesis protocol is worth 
investigating.  
4.4. Conclusion 
This study reports the use of microemulsion synthesis to produce UiO-66. This synthesis is 
achieved in room temperature conditions without the use of DMF. Hence, it shows great 
promise as an environmentally friendly synthetic protocol. Furthermore, between ωo values of 
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27.8 and 11.1 (10 to 4 mL of water) discreet pseudospherical UiO-66 crystals were obtained. 
Though, significant amorphization occurred outside this range. Within this range, NP size 
could be turned from 31.0 to 4.1 nm (the smallest UiO-66 sample in the literature) and had a 
low dispersity which remained consistent regardless of aqueous volume. Furthermore, all 
samples possessed defectivity between 0.67 and 1.71 missing linkers per unit cell. Further work 
is required to investigate tuning the defectivity of these materials. However, such a study would 
greatly enhance the results achieved in this chapter.  
4.5.Experimental Methods 
4.5.1. Materials 
As per section 2.4.1. Materials, all chemicals and reagents were sourced from commercial 
suppliers at a purity of 99.8% or greater and used without further purification.  
4.5.2. Microemulsion UiO-66 
For all UiO-66 samples prepared using microemulsion synthesis, two solutions were 
prepared by mixing TX-100 (12.48g, 18.2 mmol), 1-hexanol (4.8, 38.6 mmol) and cyclohexane 
(40 mL, 370 mmol). Two microemulsions were prepared (μEM, μEL) were prepared by adding 
a variable amount of an aqueous phase solution (Table 4.2). The aqueous phase volume of μEM  
was always equal to the aqueous volume of μEL. The aqueous phase of μEM was prepared by 
dissolving ZrOCl2.8H2O (3.22g, 10 mmol) in water (85 mL) and acetic acid (15 mL). The 
resulting mixture was heated to 60oC under reflux for 2 hours before cooling to room 
temperature. For μEL, the aqueous phase solution was prepared by adding H2BDC (1.66 g, 10 
mmol) to aqueous NaOH (100 mL, 0.2 M) and heating at 60oC until the solid was fully 
dissolved. The mixture was cooled to room temperature before further use. Once prepared, μEL 
(40 mL) was added to μEM (40 mL) dropwise over a set addition time. The solution was then 
left stirring for 24 hours. The resulting mixture was ruptured with methanol/acetone (50% v/v, 
40 mL). MOF crystals were extracted by centrifugation at 6000 rpm for 20 min. The extracted 





Table 4.2 Microemulsion UiO-66 Synthesis 
Sample Addition Time (min) Aqueous Volume (mL) 
UiO-66-10-120 120 10 
UiO-66-8-120 120 8 
UiO-66-6-120 120 6 
UiO-66-4-120 120 4 
UiO-66-3.6-120 120 3.6 
UiO-66-2-120 120 2 
UiO-66-10-30 30 10 
UiO-66-8-30 30 8 
UiO-66-6-30 30 6 
UiO-66-4-30 30 4 
UiO-66-3.6-30 30 3.6 
UiO-66-2-30 30 2 
 
4.5.3. Characterization Methods 
Samples were characterized using the method outline in 2.4.1 Characterization Methods. 
In addition, activation of samples was performed at 120oC for 20 hours under vacuum before 
gas adsorption analysis. TGA were used to further characterize the inactivated samples.  
4.5.3.1. Gas Adsorption 
Approximately 50 mg of each sample was activated by heating to 160 oC for 18 hours in a 
vacuum to remove adsorbed guest molecules. N2 was measured for the activated samples at 77 
K using a Quantachrome Autosorb IQ. Sample data was analyzed using pyGaps 2.0.2.213 
Calculations of pore size and surface area are provided in the appendix (A.2 Porosity). BET 
values calculated between for 0.2<p/p0< 0.3. Total pore volume was calculated for p/p0 = 0.98. 
4.5.3.2. Thermal Gravimetric Analysis 
TGA data was collected by heating samples (~3-10 mg) to 900oC at a rate of 5oC min-1 




Chapter 5 -  Summary & Perspective 
5.1. Future Work & Perspective 
In the previous chapters, future work was discussed when it related specifically to the 
chapter content. As a summary, in chapter two, two rare ZIF phases were found by mixing Zn 
and HIM using the microemulsion method. Whilst further exploration was outside the scope 
of this project due to time constraints, investigating whether microemulsion synthesis 
topologies could be used to tune the topology of Zn-IM MOFs represented an interesting field 
of further exploration. In chapter 3, further work was required to elucidate the impact of 
microemulsion synthesis on the activity of enzyme@ZIF-8 complexes. Finally, in chapter 4, it 
was noted that the UiO-66-4-120 sample still requires characterization by both TGA and gas 
adsorption. Furthermore, further work to investigate whether the levels of defects in the UiO-
66 samples could be tuned would greatly enhance the UiO-66 work as a whole.    
However, in this section, the focus of discussion is the general perspective on future work 
in the field of microemulsion synthesis obtained from this study. As such, it is noted that there 
were two main limitations in this study:  
Firstly, development of microemulsion synthesis protocols was largely trial and error. 
Initially it was thought that pre-existing aqueous protocols could be utilized to develop 
microemulsion protocols based on the templating model. However, the microemulsion 
synthesized MOFs displayed morphological behaviour distinctly different from the equivalent 
aqueous protocol. Whilst ZIF-8 could be synthesized using both approaches, it displayed 
substantially different morphological trends. For UiO-66, microemulsion synthesis could be 
achieved. However, no aqueous room temperature synthesis methods are available. Therefore, 
there is a limitation in the current understanding of the mechanisms behind microemulsion 
synthesis. This limits the ability to rationally develop microemulsion methods for novel MOFs.  
The second major limitation of this study was its limited investigation of reaction 
parameters. Addition rate and ωo were extensively studied. However, the cosurfactant 
concentration, pH and solvent selection amongst others were not investigated. Given the scope 
of reaction parameters in these systems, their will likely be significant room for high throughput 
screening or extensive parameter analysis for a rather long time. However, such studies are 
tedious and may not necessarily provide significant insight. For instance, UiO-66 and ZIF-8 
responded very differently to the change in ωo. No clear trend was observed for ZIF-8 in 
response to ωo. Whereas, UiO-66 reduced in NP size as ωo decreased. Hence, even after 
extensive analysis observed trends may not be generalizable.   
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Herein, it is proposed that the mechanism of MOF formation within a microemulsion 
should be studied for either UiO-66, ZIF-8, or Zn-IM. This is because current research has a 
limited understanding of the mechanisms involved in microemulsion synthesis or MOF 
formation. Providing further insight into the mechanism of MOF formation within a 
microemulsion system may prove fruitful for developing generalized rules for microemulsion 
protocols. Techniques that may prove useful to achieve this goal are: cryo-TEM, dynamic light 
scattering (DLS), in situ PXRD, and small angle X-ray scattering (SAXS). However, for 
various reasons these techniques could not be applied in this study.  
Cryo-TEM is a technique whereby samples are frozen and sliced into thin subsections 
before imaging. The technique has two advantages over standard TEM imaging. First, soft 
material (e.g. micelles) too delicate for conventional TEM are preserved by fast freezing before 
TEM analysis this allows characterization of micellular structures. Second, sample freezing 
stops the reaction process. Hence, samples can be taken from different stages in the reaction 
process allowing for time-resolved study.214 The application of this technique during 
microemulsion synthesis would allow the resolution of MOF and micellular morphology at 
different intervals throughout the formation process providing insight into possible formation 
mechanisms. 
DLS is a technique which measures the intensity and fluctuation of backscattered laser light 
transmitted through a sample. By correlating the intensity of backscattered light to the intensity 
after a time delay, the diffusion rate and hence the NP size and PSD can be calculated. Whilst 
commonly, utilized in NP analysis. The usefulness in this study was limited. Firstly, accurate 
DLS data could not be obtained for NP containing microemulsions. This could be because the 
refractive index of the samples were inaccurately determined since the refractive index of the 
structure would be the combined refractive index of the micelles and NPs. Furthermore, even 
measurement of MOF NP radius after extraction from the microemulsion proved difficult. 
Samples were freeze dried as part of the extraction procedure. Thus, agglomeration of MOF 
NPs was encouraged and homogenous resuspension of samples was difficult. Also, the porosity 
of MOFs produces extra drag during diffusion. Hence, MOF samples diffuses slower than a 
solid spherical NP of equivalent dimensions. Furthermore, DLS measures the hydrodynamic 
radius which includes the NP radius along with any molecules bound to its surface e.g. 
surfactants and water. These estimation errors tend to result in DLS overestimating the size of 
MOF NPs and not being directly comparable to the size determined by imaging.71, 81 
Furthermore, whilst DLS was available, booking requirements meant it was not available for 
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general screening. So, whilst significant attempt was made to utilize DLS its actual application 
was quite limited.  
For real time SAXS and in situ PXRD a specialized setup is required where the sample 
flows through a capillary tube in front of the detector. Furthermore, both techniques are 
generally performed at a synchrotron or with a specialized detector. This obviously precludes 
these techniques from regular usage during screening in this study. However, further 
characterization using these techniques would be particularly advantageous. In situ PXRD 
allows the discovery of topological intermediates during synthesis by measuring the PXRD of 
the solution phase sample over time.77 This would be particularly useful for topologically rich 
systems e.g. Zn-IM. SAXS is a technique whereby elastic scattering of X-rays from a sample 
are measured at small angles (0.1 – 10o). The technique allows for the determination of the 
size, shape, and distribution of nanoscale structures. In fact, it has been used previous for the 
determination of NP/ micelle shape and size in real time with non-MOF systems.105, 215  
Another area of future work is investigating new methods to synthesize MOFs in 
microemulsions. Despite developing a new microemulsion synthesis protocol for Zn(IM)2 neb 
and UiO-66 which have not previously been synthesized using this method, these syntheses are 
far from outliers in the existing literature. In both cases, the ligand used could be solubilized in 
the aqueous phase before incorporation in the microemulsion. In the case of UiO-66, BDC has 
readily been incorporated in many microemulsion MOFs. However, UiO-66 itself has not been 
synthesized. This is likely due to the challenges in synthesizing the zirconium SBU. For 
Zn(IM)2 neb, the structure chemically varies from ZIF-8 only by a methyl group. ZIF-8 has 
been extensively synthesized using microemulsion synthesis. Many MOFs use large 
hydrophobic ligands which could not be solubilized in these emulsions e.g. NU-1000 or MUF-
77. To diversify the MOFs that can be made using microemulsion synthesis a new strategy to 
solubilize the ligand is required. An interesting approach would be to move away from w/o 
microemulsions towards systems where this is more easily achieved. Whilst DMF in oil 
microemulsions would conceivably work, adding DMF is counterproductive towards the goal 
of green synthesis. Instead, future work should be focussed on ionic liquid in oil 
microemulsions. Ionic liquids are generally good solvents for organics with tuneable solubility 
parameters. These solvents are also typically regarded as more environmentally friendly than 
typical organic solvent.216 This would allow the selection of an ionic liquid based on the desired 
MOF. Furthermore, ionic liquid microemulsions have precedent since both ionic liquid in oil 
and water in ionic liquid microemulsions have been prepared.217 However, only ionic water in 
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ionic liquid microemulsions have been used in MOF synthesis making this proposal a 
substantially new area of research in the MOF field.108, 109  
5.2. Conclusions 
In chapter 1, a brief introduction was given of the history, properties, and applications of 
MOFs. Further discussion was given into how researchers have been investigating methods 
such as reaction tuning and microwave synthesis to try and control the physical properties of 
MOFs on the nanoscale. One such method was to synthesize these materials within a 
microemulsion. Whilst promising, researcher into this field has been incredibly limited. As 
such this work was intended as a broad investigation into the conditions that may affect the 
topology and morphology of nanoscale MOFs synthesize in a TX-100 non-ionic 
microemulsion system; particularly the ωo and the addition time.  
In chapter 2, this microemulsion system was applied to synthesize sod ZIF-8; one of the 
most common MOFs in the literature. Several conditions were varied including the ωo value, 
ligand to metal equivalents, and the addition time. Results of other conditions were 
inconsistent. However, changing the addition time from 0 minutes to 2 hours was a reliable 
method to change the NP size and morphology while maintaining a uniform dispersity. 
Psuedospherical particles were obtained between 0 and 30 minutes. Increasing this time further 
resulted in the formation of more typical rhombic dodecahedral, truncated rhombic 
dodecahedral and cubic crystals. As the time increased there was also a noticeable increase in 
particle size from 27.3 ± 9.1 to 87.3 ± 22.4 nm. Further work with Zn-IM demonstrated that by 
changing ωo two rare topologies were obtained (neb and unknown). 
In chapter 3, it was demonstrated that microemulsion synthesis could be utilized to 
synthesize BSA@ZIF-8 NPs. The resulting materials had high LE values up to ~17%. 
Furthermore, the particle size could be finely tuned from 69.7 ± 15.1 to 87.6 ± 24.5 nm by 
adjusting the addition time. All samples had a relatively consistent RSD between 21.6 and 
27.9%. Microemulsion synthesis was then applied to synthesize BHG@ZIF-8 crystals. BHG 
was successfully encapsulated despite the reports of significant difficulties in the literature. 
This marks the first facile and reproducible approach to synthesize this protein@MOF 
complex. Furthermore, like BSA@ZIF-8 and ZIF-8 the NP size could be tuned by modifying 
the addition time. Thus, marking this approach as a potentially generic method to produce 
tuneable sized protein@ZIF-8 NPs.  
In chapter 4, microemulsion synthesis was utilized to synthesize UiO-66. It was found that, 
when synthesized with a 120 and 30 min addition time, psuedospherical nanoparticles were 
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obtained. Furthermore, the size of UiO-66 NPs could be adjusted from 31.0 ± 8.0 to 4.1 ± 1.1 
nm by reducing the ωo value. This change in NP size was independent of the sample’s 
defectivity. Thus, microemulsion synthesis potentially offers a “defect independent” route to 
synthesizing size controlled UiO-66 NPs. Further work to investigate tuning the defectivity of 
UiO-66 within microemulsions by adjusting the addition time or pre-synthesis treatment 
temperature of the μEM aqueous phase would significantly compliment this work. 
Nevertheless, the method for synthesizing UiO-66 developed in this work offers a MOF NP 
product with sub-100 nm dimensions, precise tuneability, and low dispersity using temperature 
DMF free conditions.   
Overall, this works highlights two potential methods to tune the particle morphology of 
MOF NPs in a TX-100/hexanol w/o microemulsion: addition time and ω0 modification. As this 
field is still in its infancy, further work is still required to understand the mechanisms and 
interactions involved in microemulsion synthesis of MOFs before rational synthesis can be 
achieved. Nevertheless, the potential application for precise synthetic control and green 
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Appendix A -  Calculations  
A.1. Particle Size & Distribution 
A.1.1. Powder X-ray Diffraction 
From selected powder patterns, the length of the coherent scattering domain perpendicular 
to the plane (ϕ) could be determined from the PXRD peak associated with that plane using the 
Scherrer equation (eq. A.1), lambda is the source wavelength (0.15418 nm), B(2θ) is the peak 
broadening, and theta is the Bragg’s diffraction angle.1 
A.1    𝝓 =
𝟎.𝟗𝝀
𝑩(𝟐𝜽) 𝐜𝐨𝐬 𝜽
    
For the selected peaks, the peak was modelled with a Gaussian fit using Origin 2018 SR1 
b9.5.1.195 to deconvolute merged peaks. From these peaks, the peak broadening was defined 
as the full width half maximum (FWHM) in radians.2 Typically, instrumental broadening 
would be corrected by collecting a pattern for a bulk crystallite with negligible size induced 
broadening such as LaB6. The peak broadening would then be plotted against 2θ and then fit 
with a polynomial.3 An LaB6 standard was available and a PXRD was collected. However, the 
smallest angle peak of LaB6 is at 2θ = 21
o.4, 5 This is substantially larger than the smallest angle 
peaks measured in the samples (7.3o). Using this standard for MOFs would require significant 
extrapolation of the instrumental peak broadening for the peaks observed. Therefore, 
instrumental correction was not performed, and a better correction standard should be selected 
in future. However, it should be noted that instrumental correction is not strictly necessary in 
the context of this thesis because all samples would have been corrected by the same amount. 




A.1.2. Transmission Electron Microscopy 
The particle size was determined from TEM images using ImageJ 1.52a (Figure A.1).6 The 
scale was set by using the set scale tool to set the scale to be equal to the scale bar in the image. 
Once this was set, the image was masked with a black and white threshold. The threshold was 
set manually to include the most individual particles. In the Analyse Particles, menu the 
circularity and size filters were manually set to exclude the largest aggregates and partial 
crystals but maintain the largest number of particles possible. Finally, amorphous, or aggregate 
particles were manually excluded from the selection. The longest distance between two points 
in the particle was automatically calculated for every selected particle. In the case of 
pseudospherical particles this is approximately equal to the diameter.  
 
Figure A.1  Filtering aggregates from size analysis of TEM images. The (A) raw image is 
first (B) masked automatically to isolate all particles including aggregates. Aggregate 




A.1.3. Particle Size Distribution Modelling 
The empirical probability distribution function (PDF) was determined by plotting the PSD 
as a histogram with bins between 1 nm and 20 nm depending on the sample. Empirical PDFs 
for all samples were plotted and can be found within Appendix B. Empirical CDFs (ECDFs) 
were calculated from the raw particle size by dividing the sum of all particles less than or equal 
to a specific size (t) by the number of particles in the sample (N) (eq. A.2). The specified size 
(t) is the next largest uncounted particle in the series. E.g. For the dataset x = 1.0, 1.3, 1.6, 1.8, 
1.8, 2.2, 2.7, 2.9, 3.0, 3.1  the ECDF is represented by (x,y) = (1.0, 0.1), (1.3, 0.2), (1.6, 0.3), 




∑ 𝒙𝒊 ≤ 𝒕
𝑵
𝒊=𝟎   
For each sample where the PSD was measured, the ECDF was fitted automatically with the 
Weibull and Gaussian distribution using the implementation of least squared fitting in Origin 
2018 SR1 b9.5.1.195.  
A.1.4. Kolmogorov Smirnov Tests 
The Kolmogorov Smirnov Test is a test to determine whether two distribution are the same. 
Within this study, the Kolmogorov Smirnov Test is used to determine whether a model for the 
PSD is a good fit for the experimental data. (Figure A.2). The test compares the cumulative 
distribution of the model and sample. The maximum vertical distance (D) between the two 
samples is found (eq. A.3).  
A.3 𝑫 = 𝐬𝐮𝐩|𝑭𝟏(𝒙) − 𝑭𝟐(𝒙)|    
The null hypothesis is that the two datasets come from the same distribution. The null 
hypothesis is rejected if D is greater than the critical value (Z) which is determined from a table 




Figure A.2 Kolmogorov Smirnov Test applied to comparing two datasets (red & black) 
The Kolmogorov statistic (D) is determined as the maximum vertical distance between the two 
datasets 
The Kolmogorov Smirnoff Test was selected because non-parametric CDF test. This means 
it makes no assumptions of the distribution during the test. Furthermore, it uses the CDF instead 
of the PDF for determining goodness of fit (unlike the Chi-Squared test).8 Given the 
experimental PDF is subject to artefacts due to the arbitrary selection of bins for histogram 
plotting, a CDF test is more appropriate for this application.    
A.1.5. Particle Size Corrections using the Weibull Model 
For some samples, the Gaussian distribution did not fit the experimental data. In these 
cases, the Weibull model (eq. A.4) still maintained a good fit for the experimental PSD. To 
compare the modelled size with the experimental data, the average NP size (ϕ)(eq. A.5) and 
SD (eq. A.6) were calculated from the Weibull distribution with the shape (β) and scale (α) 



















A.6 𝑺𝑫 = 𝜶 √ 𝚪 (
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A.2. Porosity & Surface Area 
A.2.1. BET Surface Area 
The surface area of UiO-66 was determined by measuring the volume of nitrogen gas 
absorbed by the material as a function of pressure. The surface area was determined from the 
volume of absorbed gas using Brunauer Emmett Teller (BET) theory. 10It assumes that gas 
molecules are physical absorbed onto a material surface in layers and that each gas molecule 
interacts only with the adjacent layer. It further assumes the enthalpy of absorption is highest 
for the first layer (E1) and all subsequent layers have an enthalpy of absorption equal to the 
enthalpy of liquification (EL). Given these assumptions eq. A.8 and A.9 were derived with the 
equilibrium pressure (p), the saturation pressure (po), the volume of a monolayer (vm) and the 
















   
A.9 𝒄 = 𝒆
𝑬𝟏−𝑬𝑳
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. This is a linear relationship 
for 0.2 < 
𝒑
𝒑𝟎
 <0.3. From this linear relationship eq. A.10 and A.11 are derived using the gradient 
(g) and intercept (i).  
A.10 𝒗𝒎 =
𝟏
𝒈 + 𝒊 
   
A.11 𝒄 = 𝟏 +
𝒈
𝒊
   
The BET surface area is determined from eq. A.12. using Avogadro’s number (NA), the 









Figure A.3 (Inset) adsorption of gas molecules into monolayers according to BET theory. 
(outset) linear fit of BET eq. A.7. 
A.2.2. Total Pore Volume 
When calculating the total pore volume, it is assumed that all pores are fully occupied with 
condensed phase gas where p/p0 is greater than 0.95. Therefore, the total pore volume can be 
determined from the amount of N2 absorbed
* where p/p0 equals 0.99 (VN2). The adsorbed gas 
condenses when adsorbed into the pores. Therefore, the uncondensed N2 must be converted to 
a condensed volume.  For N2 at 77 K, the uncondensed to condensed volume ratio is 647. As 
the total pore volume (Vpore) is assumed to be equal to the condensed phase volume, the total 








* mL g-1: volume absorbed N2 per gram of sample 




































A.3.1. Total Defects 
The prevalence of defects was determined using the method derived by the Lillerud group11. 
Decomposition of dehydroxylated UiO-66 (Zr6O6(BDC)6) was measured during TGA under 
air at ~500oC. During this step, it is assumed that dehydroxylated UiO-66 decomposes to ZrO2 
(eq. A.14) and that no other decomposition steps occur at this temperature.  
A.14   𝒁𝒓𝟔𝑶𝟔(𝑩𝑫𝑪)𝟔  +  𝟑𝑶𝟐 → 𝟔𝒁𝒓𝑶𝟐 + 𝟔𝑩𝑫𝑪    
From this assumption, the mass of 6 ZrO2 molecules is normalized at 100% mass. E.g. 
complete decomposition mass. Ideal UiO-66 has a formula mass of 220% the mass of 6 ZrO6. 
Hence, any decomposition less than that implies the loss of BDC. From this assumption 
Lillerud derived the equation for the number of missing linkers per unit cell (x) (eq. A.15). 
A.15     𝒙 = 𝟔 −
𝑵𝑳−𝟏𝟎𝟎
𝟐𝟎.𝟎𝟑
   
The percentage of defects is the number of defects per unit cell divided by the number of 
BDC linkers in an idealized unit cell (6) multiplied by 100 (eq. A.16) 
A.16          % 𝑫𝒆𝒇𝒆𝒄𝒕𝒔 =  
𝒙
𝟔
∗ 𝟏𝟎𝟎   
The number of defects per unit cell was determined by multiplying the defect percentage 
by the number of BDC molecules in a non-defective crystal (6) (eq. A.17). 









A.3.2. Surface Defects 
On the outer surface of any extended network, local sites may not adhere to the unit cell 
formula due to termination of the network. For large networks, this effect is negligible. 
However, as the crystal dimensions shrink, the outer surface becomes a larger proportion of 
the overall surface area. Hence, if a crystal is small enough, it will appear defective regardless 
of the presence of internal defects. To model this effect on UiO-66 two assumption were made: 
1. UiO-66 growth is along the [111] face and the overall morphology is octahedral.  
2. The crystal has a net neutral surface charge.   
The assumption of an octahedral morphology is generally reasonable for UiO-66. 
Furthermore, octahedral growth is easier to model. However, the samples in this study do not 
follow this morphology and instead have a pseudospherical morphology. Given, that the 
surface area for an octahedral is smaller than a sphere of the same length. This model would 
underestimate the contribution of surface defects to the overall defectivity. This is reasonable 
in the context it is applied. The second is assumption that the crystal surface is net neutral 
would imply the surface is populated by hydroxide or acetic acid capped zirconium clusters. 
This assumption is used often in the literature.  
 A fully occupied UiO-66 cluster has 12 coordination sites with 4 sites above, below and 
in-plane. Hence, each cluster coordinates four clusters above or below it towards the centre. 
Therefore, the primitive (smallest possible) octahedron (n=1) was thought of as three planes 
with 1,4 and 1 clusters in each plane. The second smallest octahedron (n=2) would consist of 
1,4,9,4,1 clusters. The value n was determined to be the particle length (Φ) divided by the UiO-
66 octahedron length (Lo) rounded to the nearest integer (eq. A.18).   







There are four possible arrangements of a cluster within an octahedral. It can be on the 
edge, face, vertex, or buried within the octahedral. The number of each is a function of the 









𝑵𝒗𝒆𝒓𝒕𝒆𝒙 𝒄𝒍𝒖𝒔𝒕𝒆𝒓 = 𝟔 
𝑵𝒆𝒅𝒈𝒆 𝒄𝒍𝒖𝒔𝒕𝒆𝒓 = 𝟏𝟐(𝒏 − 𝟏) 




𝑵𝒃𝒖𝒓𝒊𝒆𝒅 𝒄𝒍𝒖𝒔𝒕𝒆𝒓 = 𝒏




𝑵 𝒄𝒍𝒖𝒔𝒕𝒆𝒓𝒔 = (𝒏 − 𝟏)








By bisecting the outer surface clusters with the surfaces they contact the number of BDC 
substituted at the surface was determined. For a buried cluster, all ligands would be present. At 
a vertex there are four ligands and eight modulators bound. At an edge there are seven ligands 
and five modulators bound. At a face there are 9 ligands and 3 modulators bound. The number 
of ligands in the cluster is half the number of ligand binding sites available to each cluster 
because each ligand has a connectivity of two (eq. A.20). 
A.20 𝑵 𝒍𝒊𝒈𝒂𝒏𝒅𝒔 = 𝟔𝒏
𝟐 + ∑ 𝟏𝟐𝒊𝟐𝒏−𝟏𝒊=𝟏 + 𝟒𝟐(𝒏 − 𝟏) + 𝟐𝟒 + ∑ 𝟑𝟔𝒊
𝒏−𝟐
𝒊=𝟏  
The defect percentage was determined by finding the ratio of ligands clusters and dividing 
as a percentage of the idealized UiO-66 formula. Ideal UiO-66 has 6 BDC linkers per cluster 
(eq. A.21) 










A.4. Protein Properties 
A.4.1. Isoelectric Point 
For each protein, the isoelectric point was estimated from the amino acid sequence by 
summing the charges of all amino acid residues using the Henderson-Hasselbalch equation (eq. 
A.22).  





The pI was determined as the pH where the net charge on the protein was 0 ± 0.0001. The 
average residue pKa values and the final pI where determined using Expasy
12. 
A.4.2. Loading Efficiency 
The loading efficiency (LE) was defined as the percentage mass of protein encapsulated 
out of the total mass of the protein@MOF complex (eq. A.23).  




The LE was determined using a Bradford Assay. During a Bradford assay, Coomassie Blue 
G-250 is added to a protein@ZIF-8 complex. In acidic conditions (pH > 5), ZIF-8 degrades 
releasing the protein. Coomassie Blue G-250 binds to the amino and aromatic groups of the 
protein. This causes a shift in the dye’s UV-vis absorption peak from 465 to 595 nm.13 A 
calibration curve was obtained for the increased absorbance at 595 nm (Abs595) as a function 
of protein quantity (m). For BSA (Figure A.4), the absorbance is represented by eq. A.24. 
A.24  𝑨𝒃𝒔𝟓𝟗𝟓 = 𝟎. 𝟎𝟎𝟏𝟏𝟗 𝒎𝑩𝑺𝑨 
The LE was determined by dividing the amount of BSA determined from UV-vis by the 
amount of BSA@ZIF-8 digested (A.25).  






























Figure A.4 Bradford assay calibration curve measuring absorbance at 595 nm. Abs = 
0.00119*BSA 
 
A.4.3. Encapsulation Efficiency 
The encapsulation efficiency or the percentage protein encapsulated of the total protein 
added (eq. A.26) is calculated by multiplying the fraction of protein in the protein MOF 
complex by the total yield of complex (mg). This is then divided by the total amount of protein 
added to μEL. This is expressed as the protein concentration (mg mL-1) multiplied by the 
volume of aqueous phase in μEL (1.8 mL)(eq. A.27). 
A.26  𝑬𝑬 = 𝟏𝟎𝟎 ∗
𝒎𝒑𝒓𝒐𝒕𝒆𝒊𝒏 𝒆𝒏𝒄𝒂𝒑𝒔𝒖𝒍𝒂𝒕𝒆𝒅
𝒎𝒑𝒓𝒐𝒕𝒆𝒊𝒏 𝒕𝒐𝒕𝒂𝒍  
 







Appendix B -  Experimental Data 
Table B.1 ZIF PSD modelling Parameters  
 Weibull Gaussian Test 























































































































































Figure B.1 Additional TEM images of ZIF-8a-1x. 
 
 
Figure B.2 PSD of (A) ZIF-8a-1x and (B) ZIF-8d-120. (C) Cumulant distribution of sample 
PSDs with a Weibull fit. 
 
























































































































































Figure B.3 PSD of ZIF-8 synthesized using variable addition times.  
 
Table B.2 TEM determined ZIF-8 samples synthesized with variable addition times 
Sample Φ (nm) N SD (nm) RSD (%) 
ZIF-8b-0 27.3 103 9.13 33.4 
ZIF-8b-15 52.7 102 14.4 27.3 
ZIF-8b-30 74.6 107 18.0 24.1 
ZIF-8b-60 77.0 100 18.9 24.7 
ZIF-8b-90 78.2 118 25.7 32.8 
ZIF-8b-120 87.3 131 22.4 25.6 









































































0 min                                                     15 min                                                     30 min
60 min                                                      90 min                                                   120 min
144 
 













Figure B.4 Simulated PXRD of 5 nm ZIF-8 crystallite. Simulated using CystalMaker 10.4.2. 
 
 
Figure B.5 PSD of ZIF-8 synthesized with various aqueous volumes  
 
 




































































4 mL                                                          3 mL                                                           2 mL
1.8 mL                                                         1 mL     
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Table B.3 TEM determined ZIF-8 samples synthesized with variable addition times 
Sample Φ (nm) N SD (nm) RSD (%) 
ZIF-8c-4 60.0 165 22.0 36.7 
ZIF-8c-3 39.9 218 15.9 39.3 
ZIF-8c-2 57.8 138 20.4 35.3 
ZIF-8c-1.8 74.6 107 18.0 24.0 




Figure B.6 ZIF-8 and ZIF-67 PSD synthesized using microemulsion synthesis.   

























ZIF-8                                                                                               ZIF-67
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Table B.4 Protein@ZIF-8 PSD modelling Parameters  
Sample Φ SD Test 
BSA@ZIF-8a-2.5 57.99 15.73 Pass 
BSA@ZIF-8a-5 82.35 21.68 Pass 
BSA@ZIF-8c 72.22 16.98 Pass 
BSA@ZIF-8b-15 69.72 15.09 Pass 
BSA@ZIF-8b-120 87.59 24.48 Pass 
BHG@ZIF-8-15 55.92 22.40 Pass 
BHG@ZIF-8-30 62.58 21.73 Pass 





Table B.5 Summary of Protein@ZIF-8 NP size determined by TEM 





Φ (nm) N SD (nm) RSD (%) 
ZIF-8b-15 -- -- 15 52.7 102 14.4 27.3 
ZIF-8d-30 -- -- 30 74.6 107 18.0 24.1 
ZIF-8d-120 -- -- 120 87.3 131 22.4 25.6 
BSA@ZIF-8a-2.5 BSA 2.5 30 58.0 132 15.7 27.1 
BSA@ZIF-8a-5 BSA 5 30 82.3 113 21.7 26.3 
BSA@ZIF-8c BSA 10 30 72.2 119 17.0 23.5 
BSA@ZIF-8b-15 BSA 10 15 69.7 103 15.1 21.6 
BSA@ZIF-8b-120 BSA 10 120 87.6 108 24.5 27.9 
BHG@ZIF-8-15 BHG 10 15 55.9 105 22.4 40.1 
BHG@ZIF-8-30 BHG 10 30 62.6 107 21.7 35.3 
BHG@ZIF-8-120 BHG 10 120 75.3 103 29.9 39.7 
 
 
Figure B.7 SDS treatment of  ZIF-8 surface coated with BSA. 
 
* This is the amount of protein per mL of aqueous 2-methylimidazole. 














































Figure B.9 PSD of BSA@ZIF-8 samples synthesized with variable quantities of BSA 
 
  




















































ZIF-8                                                 BSA@ZIF-8 2.5 mg




Figure B.10 PSD of BSA@ZIF-8 samples synthesized with avariable addition times. 
 




























































































BSA@ZIF-8 15 min                                   BSA@ZIF-8 30 min                                    BSA@ZIF-8 120 min
ZIF-8 15 min                                                ZIF-8 30 min                                              ZIF-8 120 min
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Table B.6 PSD modelling parameters of UiO-66 samples 
 Weibull Gaussian Test 







































































































Figure B.12 PXRD of simulated UiO-66 (black) and UiO-66 synthesized using Pakamore’s 








 (%)* Φave (nm)
† Φ[111] (nm)  Φ[002] (nm) Φ[006](nm) 
UiO-66-10-120 4.78 16.33 16.82 14.19 17.98 
UiO-66-8-120 7.22 12.72 12.44 11.51 14.21 
UiO-66-6-120 6.88 12.79 12.76 11.75 13.87 
UiO-66-4-120 10.49 10.40 8.98 11.08 11.15 
UiO-66-3.6-120 16.92 -- -- -- -- 
UiO-66-2-120 37.53 -- -- -- -- 
UiO-66-10-30 6.50 13.67 13.75 12.17 15.09 
UiO-66-8-30 10.00 11.78 11.12 11.45 12.75 
UiO-66-6-30 9.55 10.74 9.80 10.52 11.90 
UiO-66-4-30 12.14 10.26 10.66 8.71 11.40 
UiO-66-3.6-30 23.76 -- -- -- -- 




* Relative intensity of the [001] to [111] peaks 




Table B.8 Summary of UiO-66 particle sizes determined by TEM 
Sample Φ (nm) N SD (nm) SD (%) 
UiO-66-10-120 31.0 141 7.99 25.8 
UiO-66-8-120 20.2 125 5.41 26.8 
UiO-66-6-120 14.6 101 3.56 24.3 
UiO-66-4-120 4.09 107 1.05 25.7 
UiO-66-3.6-120 -- -- -- -- 
UiO-66-2-120 -- -- -- -- 
UiO-66-10-30 26.0 119 4.40 16.9 
UiO-66-8-30 17.4 115 5.13 29.5 
UiO-66-6-30 12.6 100 2.76 22.0 
UiO-66-4-30 -- -- -- -- 
UiO-66-3.6-30 -- -- -- -- 






Figure B.13 Experimental PSD of microemulsion synthesized UiO-66 samples with a 
Weibull fit. 
  
























































































UiO-66-10-120                                                  UiO-66-8-120                                                   UiO-66-6-120
 UiO-66-10-30                                                    UiO-66-8-30                                                     UiO-66-6-30
 UiO-66-4-120  
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Table B.9 TGA Decomposition Temperatures and Defectivity of UiO-66 samples  
Sample Decomposition 
Step 1 (oC) 
Decompositon 




UiO-66-10-120 256 479 199 17.5 
UiO-66-8-120 310 492 205 12.9 
UiO-66-6-120 301 487 206 11.2 
UiO-66-10-30 222 & 289 501 194 21.8 
UiO-66-8-30 246  499 186 28.5 





Appendix C -  Structures 
 
Table C.1 Protein Structures Obtained from the Protein Data Bank (PDB) 
Protein Bovine Serum 
Albumin 
 Haemoglobin 
PDB ID 4F5S15  1HDA16 
Organism  Bos taurus  Bos taurus 
Mass (KDa) 66.6  64.6 
Residue Number 1160  572 
pI (Calculated)*  5.60  8.19 
Length (nm)† 14.9  6.62 
Width (nm) 8.14  5.76 
Depth (nm) 6.14  5.37 
 
Table C.2 CCDC18 Accessed Structures 
MOF Metal Cluster Ligand Topology CCDC Ref.‡ Reference 
MOF-5 Zn4O BDC pcu MIBQAR 19 
HKUST-1 Cu2(CO2)4 BTC tbo BODPAN 20 
NU-1000 Zr6O4(OH)4 TABPy§ csq FIFFUX 21 
NU-901 Zr6O4(OH)4 TABPy scu --** 22 
ZIF-8 Zn2+ mIM sod FAWCEN 23 
ZIF-L Zn2+ mIM 2D-Sheets IWOZOL 24 
ZIF-67 Co2+ mIM sod GITTOT02 25 
Zn(IM)2 neb Zn2+ IM neb KEVLEE 26 
UiO-66 Zr6O4(OH)4 BDC fcu RUBTAK 27 
 
 
* The pI was calculated using the Henderson-Hasselbalch equation (A.4.1 Isoelectric Point) 
† Protein dimensions were calculated from the PDB structures using the Draw_Protein_Dimensions.py script from 
the Pymol script repository17 
‡ Cambridge Crystallographic Data Centre entry reference 
§ 1,3,6,8-tetrakis(p-benzoic acid)pyrene 
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